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INTRODUCTION 
The increased use of tissue culture and electron 
microscopy as diagnostic tools in small animal medicine has 
recently led to the addition of canine coronavirus (CCV), 
canine parvovirus (CPV), and rotavirus to the list of 
- . . -
viruses associated with enteritis .in the dog. In contrast 
to ·CCV which was apparently present in the canine population 
for some time before it was associated with enteritis, CPV 
appears to be a new pathogen of dogs. 
Soon after CPV was recognized, it was shown to be 
serologically indistinguishable from feline panleukopenia 
virus (FPV). This serological relationship led to the use 
of FPV vaccines in dogs in an effort to prevent CPV 
infection. But, their efficacy in dogs had not been 
established • 
. The present study deals with the relationship of CPV to 
FPV and to mink enteritis virus (MEV), another serologically 
related parvovirus. The study was undertaken to discover 
markers that could distinguish ind1v1dual,1solates of CPV, 
FF>V, and MEV and to evaluate .the ant1gen1c relationship of 
CPV and FPV by determ1n1ng 1f FPV vaccines could, 1n fact, 
be used to protect dogs against .CPV enteritis. To 
accomplish this latter objective, a vacc1nat1on-challenge 
procedure .had to be established .• 
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LITERATURE REVIEW 
Enter1c Viruses of the Dog 
V1ra1 enter1 tis in the dog man1f.es ted by vomiting and 
diarrhea has long been associated with systemic infections 
of canine distemper virus and infectious canine hepatitis 
virus (Severin, 1968). In neither case, are the symptoms 
confined to the gastrointestinal system. 
In 1971, Bi.nn .2.!: al. ( 1975) isolated a corona virus 
from military dogs in Germany that were undergoing an 
epizootic of diarrheal disease. The virus was shown by 
serum neutralization studies to be antigenically related to 
transmissible gastroenteritis virus (TGE), a coronavirus of 
swine, but swine anti-TGE sera neutralized the canine 
coronavirus virus at one-sixteenth the level it neutralized 
TGE virus. Infectivity studies conducted in neonatal and 
2.5-month-old seronegative pigs indicated that a tissue 
culture preparation of the canine origin virus was not 
pathogenic for or able to cause seroconversion in swine, 
In dogs, diarrhea could be experimentally produced in 2 
litters of J- to 5-day-old pups, but the dams remained 
asymptomatic. All the dogs seroconverted. The passage of 
the virus in tissue culture may have affected its virulence 
for adult dogs. 
In 1972, an outbreak of acute diarrhea, vomiting, and 
anorexia occurring in dogs at a breeding kennel was reported 
from England (Cartwright and Lucas, 1972), Although the 
younger pups in the kennel appeared to show more seTere 
signs, all the dogs were infected and one of the 40 dogs 
died, a 3-week-old pup. No pathogenic bacteria were 
isolated and attempts to isolate virus in a canine kidney. 
cell' line and primary porcine kidney cells failed. Sera 
collected at intervals following t},le outbreak showed a. r~se 
in antibody titer to TGE virus although ~one of the d0gs 
had access to pigs, The serological evidence would ind,~cate 
that CCV was 1n'1!'01Ted in this outbreak~ 
The presence of ant~-TGE.antibody in the dog population 
was discovered prior to the isolation ot CCV by Binn ~ !l• . ''\ 
(~9.75) ~ Baelterman (1962) reported that dogl!I and foxes ted 
TGE Tirus infected pill> gu1; ~o~d shed the Tirus for at least 
7 days and. show seroconversion by a consta~t serum-varying 
Tirus neutralization test. No clinical symptoms were 
obserTed in any or the animals. This led Norman et ·al, (1970) --
to eTaluate the incidence of TGE antibody in dogs from the 
midwest United States, Serum samples from 116 dogs with 
different hist~ries were tested. Only dog$ trom a 
h¥sterectomy-derived closed colony were consistently free of 
antibody •. Adult dogs of J!lixed brseding, adult beagles from 
a closed colony, and 6- to 10-week-old beagle pups from 3 
ditferent.commer~ial suppliers of laboratory animals had 
antibody to TGE. In all, 72 dogs which had no contact with 
4 
swine were positive indicating the antibody was to a viral 
agent. that could perpetuate itself in dogs. Higher antibody 
' 
titers were seen in tbe older animals which the authors 
attributed to either persistent or recurrent infections. 
The possibility of low level maternal antibodies in the P¥PB 
was not considered. 
Additional studies conducted by these same investigators 
(McClurkin !! !!·, 19'70) dealt with the pathogenicity of TGE 
virus for dogs. Eleven dogs were fed 0.45 micron filtered 
TGE infected gut material twice at 21 day intervals. No 
clinical signs were observed and viral isolation attempts 
from fecal swabs using swine testicle cells failed on all 
but one sample taken at 2 days after the first feeding. 
Composites of rectal swab material from all 11 dogs taken 
'7 .and 14 days after the first feeding did produce disease 
typical of TGE in 2-day-old piglets. Of the 11 dQgs, only 
9 showed seroconversion, '7 at only 1:5, and the antibOdy 
levels obtained were generally lower than those seen in 
their previous survey (Norman et al., 19'70). The work 
. --
indicated, as dogs that of Haelterman (1962), that TGE can 
replicate in dogs and dogs can transmit TGE to pigs. 
Howev.er, the low incidence of virus in the feces and the fact 
that only 9 of 11 dogs serologically converted after two 
oral doses of virus leaves doubt that TGE virus perpetuates 
itself in dogs. This would suggest that the antibody titers 
s 
seen 1n the earl1er study (Norman ,2! !!·, 1970) were due to 
CCV and not TGE virus. The CCV may have been subcl1n1cal 
s1nce no enter1t1s assoc1ated w1th the dogs had been 
mentioned. 
In 1977, Eugster and Na1rn (1977) reported a case of 
d1arrhea 1n a 11tter of 9-day-old pups. The feces were 
descr1bed as be1ng th1n, watery, and 11ght tan 1n color but 
returned to normal by 11 days. The diarrhea was not con-
sidered severe and no other clinical signs were c;ibserved. 
Parasitological and bacteriological examinations of the feces 
were negative but a cytopathic effect (CPE) with total cell 
destruction in o days was observed when a fecal preparation 
was inocUl.ated onto Madin-Darby canine kidney (MDCK) cells. 
By the third tissue culture passage, no CPE was observed and 
no CPE was ever detected with pr1mary canine cells. Electron 
microscopic stUd1es of the fecal material and the f1rst two 
MDCK passages revealed l~-20 nm diameter particles which, 
l;>ecause of their morphology, were considered to be parvo-
y1ruses. The fact that the virus could not be maintained in 
tissue culture made it impossible to experimentally determine 
if the parvovirus was the causative agent of the diarrhea 
seen in the pups. It should be noted that Binn ,2! al. (1970) 
previously recovered a parvovirus, designated the minute 
virus of canines (MVC), from apparently normal dogs. Of 2J 
cell types tested, MVC would only grow in a canine cell iine 
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de:v1ved from a subdermo1d oyst, but the susoept1b111ty of 
MDCK oells was not deter1111ned. No pathogen1o1ty has been 
assoo1ated w1th MCV but serological studies have indicated 
it is widespread (70 percent) in the dog population (Siegl, 
1976). Th1s author suggests that the v1rus isolated by 
Eugster and Nairn (1977) may have been MVC. 
In July 1978, an ep1zoot1c of contagious and sometimes 
fatal gastroenteritis in show dogs was reported with the 
initial case being observed in m1d-March (Carmichael, 1978). 
There were vomiting and diarrhea w1th variable amounts of 
mucus and blood 1n the feces, The feces, wh1ch was often 
11orangish 11 , was exceptionally foul smelling. An1mals 
generally recovered in 7 to 10 days, however, there were some 
deaths reported, part1cularly in young pups. A coronavirus 
was rewovered 1n cell culture from 5 w1dely separated 
outbreaks, and the isolates were shown to be serologically 
related to the CCV prev1ously 1solated by B1nn !! !!· (1975) 
(Appel !! !!·, 197tl). Exper1mental CCV infection resulted 1n 
1111ld symptoms of diarrhea or soft reces which persisted for 1 
to 2 weeks in some dogs while others remained asymptomatic. 
The reason for the sudden occurrence of an enteric syndrome 
associated with CCV 1nfectio:n is not clear since studies 
indicated 1t was prevalent in the United States prior to i978 
(Appel !! !!·, 197tl; Norman il al., 19'/0). The number of 
cases being reported decreased dramatically a:rter a few months. 
7 
In the summer of 1978, Eugster et !l· (1978a, 1978b) 
noted cases of enteritis in dogs in which massive numbers 
of parvoviruses could be observed in intestinal contents by 
electil"on microscopy, The clinical. syndrome was reportedly 
different than that observed earlier with parvovirus 
assocfated diarrhea (Eugster and Nairn, 1977) and resembled 
feline panleukopenia both clinically and histologically. 
The morbidity approached 100 percent and the mortality 
ranged from 10 to 50 percent with the higher rates being 
seen in the younger animals. The clinical syndrome assumed 
epidemic proportions in certain areas of Texas. 
S1m,ilar outbreaks of canine enter! tis resembling feline 
panleukopenia were occurring simultaneously in Canada 
(Thomson.and Gagnon, 1978), Australia (Kelly, 1978), and 
England (Jefferies and Blakemore, 1979). A definite 
relationship between the canine parvovirus (CPV) and FPV 
was established when it was shown that intestinal 
epithelium from cases of enteritis in which CPV was 
isolated, fluoresced when stained with FPV conjugate (Black 
et!!,., 1979). These same authors demonstrated a high level 
of cross-reactivity between the two viruses with a serum 
neutralization (SN) test. Cross-reactivity was also observed 
with hemagglutination inhibition (HI) tests by which CPV and 
FPV could not be differentiated (Johnson and Spradbrow, 
'" ' 
1979). However, the fact that CPV would hemagglut1nate 
8 
porcine and monkey erythrocytes at 4 and 25°c was said to 
differentiate it from FPV which reportedly only agglutinates 
porcine erythrocytes and then only at 4°c (Johnson and 
Cruikshank, 1966). 
At approximately the same time as· the canine enteritis 
outbreaks, a sudden death syndrome was occurring in young 
puppies in which the primary lesion was myocarditis. A viral 
etiology was assumed because lntranuclear inclusion bodies 
were noted in myocardial cells (Kelly and Atwell, 1979; 
Huxtable et al., 1979; Thompson et a1.,·1979), and on -- --
ultrastructural examination, these inclusion bodies contained 
particles which closely resembled parvoviruses (Hayes .21 al., 
1979b). Subsequently, the fluorescence of myocardial 
inclusion bodies stained with canine orlgin conjugate specific 
for the canlne enteritis parvovirus (Hayes ,21 !1,., 1979a) and 
the presence of both myocarditis and enteritls in the same 
animal (Jefferies and Blackmore, 1979) suggested that the 
two sy.ndromes were caused by the same virus; canine 
parvovirus. 
In 1979, Eugster and S1dwa (1979) reported the presence 
of a rotavirus and an apparent plcornavirus in the feces of 
a dog wlth diarrhea. The pup was from a pet store in which 
dogs were known to be infected wlth CPV and Giardia. No 
lsolatlon and subsequent pathogenlclty studles were conducted 
so the role of the vlrus ln causlng the dlarrhea could not be 
9 
established. 
Rotaviruses have also been reported in feces and 
'.intes.tinal conteats of. dogs with diarrhea submitted for 
electron microscopic examination in the United States 
· (Pollock and Carmichael, 1979) and in England (McNulty tl 
a1.; 1980). A serological survey indicated that 49 of 62 
dogs from tile Belfast area had antibodies to rotavirus 
(McNulty !! ~·, 1978). The actual role of rotavlruses in 
canine enteritis is not clear since human rotaviruses will 
inf~ct pups without ca.using clinical diarrhea (Tzipori and 
Makin, 1978). 
England and Poston (1980) reported the isola:tion of a 
' ' 
rotavirus from a J-day-~ld pup with fatal diarrhea in which 
·the virus was propagated in .MDCK. cells through at .least 11. 
subpassages. Intestinal co~tents from the pup were orally 
inoculated into two healthy 6-month-old beagle dogs but the 
dogs remained asymptomatic and virus was not observed in the 
fec~s. It was suggested by the authors that the failure to 
induce disease may have been due to. the animal,s age but this 
does not explain the lack of virus in ~he feces since 
rotavirus infections, some subclinical, can occur in other 
animals at all_ ages (Woode and Crouch, 1978). Serological 
studies were not reported and the failure to achieve 
infe_ctlon may have been due to the immunity of the dogs by 
prior exposure to a rotavirus. 
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Canine Parvovirus 
As previously discussed, outbreaks in dogs of enteritis 
and myocarditis of apparent parvoviral etiology occurred on 
several continents during the summer of 1978. Retrospective 
serological studies have been conducted by several authors 
to determine if the associated agent, CPV, epidemiologically 
resembled canine coronavirus which was widespread in the dog 
population prior to being associated with a disease syndrome, 
or if CPV was a primary pathogen that had Just entered a 
naive dog population thereby accounting for the rapid spread 
of the virus. 
The earliest canine sera in which CPV antibody could be 
detected were from Europe. Three of 56 sera collected from 
dogs in Belgium between June 1976 and June 1977 were found 
to be positive by an HI test (Schwers, et~ •• 1979). 
osterhaus ~ al. (1980b) reported positive serological 
results from one serum collected at the end of 1977 in the 
Netherlands. They also reported that both the enteric and 
cardiac forms of CPV infection were occurring at that time. 
In Australia, Johnson and Spradbrow (1979) reported 
that no HI antibody could be detected in 22 serum samples 
collected in Townsville, Queensland, in 1976 while sera 
collected in the latter part of 1978, after clinical oases 
of CPV were observed, were positive for CPV antibody. No 
testing of 1977 serum samples was reported. 
11 
A larger serological study (428 samples) was conducted 
in New South Wales, Australia, by Walker~!!_. (1980). Of 
the 150 serum samples collected in 1978 from dogs of unknown 
history, 19 had HI antibody titers ~1:256 with the first 
positive serum being. collected in May. None of the 74 sera 
collected froin· 1969 to 1977 were positive. The authors 
reported that 35 of 45 sera from clinically normal dogs in 
breeding colonies were positive and attributed these findings 
to widespread subclinioal infection. Prior vaccination with. 
FPV vaccine was considered not to be a factor since none of 
the 20 sera tested from FPV vaccinated cats had antibodies 
to CPV ~1:256 by the HI test. This is in disagreement with 
vaccination trials reported by Appel et !l· (1979) where HI 
titers of >1:256 were commonly seen in dogs vaccinated with 
FPV vaccines. In addition, Carmichael et al. (1980) reported 
' --
HI titers to CPV of >1:2,500 in cats given live FPV. 
' -
In the United States, 95 sera from Tennessee dogs with 
undisclosed histories were tested for CPV antibody using an 
indirect fluorescent antibody test (Black~!!,. 1979). 
Seven of JO sera collected in 1978 were· positive while 27 
sera from 1977 and J8 sera from 1976 were negative. 
Carmichael ~ al. (1980) test.ad 757 sera from across the 
United States submitted primarily for canine brucellosis 
testing and JOJ serum samples submitted from June 1978 to 
June 1979 from dogs with suspected viral enteritis. None 
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of the 139 serum samples rece1Ted from 1971 to 1975 or the 
177 sera received in 1977 had HI titers ~1:320, the level the 
authors felt was .a definite indication of CPV infection. Of 
171 sera submitted from January to June 1978, three received 
in late June for canine brucellosis testing were posltiTe; 
one from Pennsylvania and two from California. An 
additional serum from a dog recently imported from.Hong Kong 
and submitted for brucellosis testing was.positive in early 
July 1978. The percent of positive sera rose to 
approximatel7 20% by August and September of 1978 but this 
rate was biased since most of the sera from this period were 
being submitted for diagnosis of enteric illness. The sera 
received prior to June 1978 were from purebred dogs and 
co11mercial breeding kennels located in many regions of the 
United States. Because of the high degree of mobility and 
interaction with breeding and show dogs, it ls felt by this 
author that CPV would appear in these dogs very soon after· 
its introduction into the United States and then spread 
rapidly among them. The rapid increase in the number of 
positive sera collected from widely distributed areas of the 
United states would tend to support this hypothesis. It is 
therefore felt tpat CPV did not exist in the dog population 
of the United States 11uchbefore the summer of 1978, and it 
was imported from some other continent such as Europe where 
it had been detected at least a year earlier. 
lJ 
The actual source of CPV may never be determined but 
the close serological relationship with FPV and MEV suggests 
that .it resulted from a mutation in one of these viruses that 
broadened its species specificity to include dogs, A 
similar phenomenon is believed to have occurred with MEV. 
Felini:i panleukopenia was recognized as a clinical entity in 
the latter half of the last century but was thought to be a 
bacterial infection (Croghan, 1968). In 1928, filtration 
studies indicated that it was p~obably caused by a virus 
(Verge and Christoforoni, 1928), and by 19J4 a formalized 
vaccine had been developed (Leasure !1 .!!!•, 19J4). Mink 
enteritis, on the other hand, was not recognized until 1947 
when it caused an outbreak.of enteritis on a mink ranch in 
the Fort Williams area of Ontario, Canada (Schofi.eld, 1949) • 
. The virus slowly spread throughout North America and was 
world-wide by 1960 (Burge:r and Gorham, 1970), It is felt 
that MEV. is a mutant of FPV that has become adapted to mink. 
Clinico-Patholog1oal Features 
The effect 2f.. age 
Canine parvovirus has been associated.with two distinct 
clinical syndromes, myocardi tis and enter-i tis, with the age 
of the animal being an influential factor in determining 
which'clinioal manifesta~ion is seen. Myocarditis is 
> 
usually a disease of young pups 4 to 8 weeks of age (Jezyk 
14 
.!!1 !!!·· 1979; Mulvey .!!1 al., 1980) although deaths due to 
myocardial scarring have been. reported in dogs up to 5 
months of age (Robinson et al., 1980a; Carpenter et al., -- --
1980). Clinical signs of the enteric form of CPV infection 
are more severe in pups 6 weeks to 6 months of age but, 
unlike the myocardial form, older adult dogs can also be 
infected (Fritz, 1979; Harcourt!,!!!·• 1980), It has been 
possible to experimentally produce the enteric form of CPV 
with virus isolated from cases of myocarditis (Hayes!,!!!·• 
1979a; Robinson!,!!!·· 1980b) but myocarditis has not been 
experimentally produced except by !,!! utero inoculation of 
virus of myocardial origin (Lenghaus !,! !!·• 1980), 
Parvoviruses require dividing cells in order to 
replicate (Rhode, 1973; S1egl, 1976) and this dependency on 
cells that are mitotically active may accQunt for the age 
differences seen with the two forms of CPV infection. 
Myocardial cell division is maximal in pups during the first 
3 weeks of life (Bishop, 1972) while the mitotic index of 
intestinal epithelial cell in the neonate compared to older 
a.nimals is relatively low. By comparing migration rates of 
tritiated thymidine labeled intestinal epithelial cells in 
rats of various ages, Koldovsky .!!1 !!• (1966) •howed that the 
rate of cell proliferation in suckling rats was one-fourth of 
that seen 1n weanling or adult rats. A similar study 
conducted in pigs (Moon, 1971) indicated that the rate of 
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cell division in the 1-day-old pig was one-third that seen 
in the J-week•old pig. It is hypothesized by this author 
that a similar situation ooours in the intestinal epithelial 
oells in the dog. Therefore., if a pup is exposed to _parvo-
virus in the first 4 to 6 weeks of age, the virus replicates 
' in the mitotically active myooardial cells producing ~yooar-
ditis. The virus manages to produce only a low level infec-
tion in the gut with limited pathogenesis beoause of the low 
number of dividing cells. However, if the pup is exposed to 
parvovirus after weaning,. the rate of myocardial cell divi-
sion is reduced and myooardites does not develop but the 
increased mitotic actively .in the gut allows for extensive 
virus replication and cell destruction resulting in enteritis. 
'!'he study by Csiza !.!:_ !!_., (1971) supports this hypoth-
esis. They examined the pathogenesis of FPV in newborn 
kittens and observed severe enterio lesions in only J of 21 
cats although it is a consistent finding in older animals. 
The reason for the relative lack of enterio involvement in 
newborn oats was not given but may have been due to a 
decreased rate of intestinal cell proliferation •. In studies 
conducted with FPV in germfree and specific pathogen free 
(SPF) oats (Rohovsky and Griesemer, 19b7; Carlson et al-~, 
. --
1977), it was observed that, as in the neonate, _the enterio 
lesions in the germfree oats were considerably less severe 
than those seen in SPF oats. However, differences in degree 
16 
of thymlc 1hvolut1on or leukopenia, both signs of FPV 
infection, dld not occur between the two types of oats. 
Carlson and Scott (1977) determined that mucosal crypt 
length, cells per crypt, mitotic index and vlllous length 
were greater ln SPF cats than ln germfree cats and 
suggested that either bacteria or their metabolic by-
products present ln the SPF oats were responsible for the 
differences. They felt the lower mitotic index and lower 
number of cells per crypt ln the germfree oat decreased the 
chance of PPV replication ln the gut and thus the severity 
of the lesions produced. 
Myocarditls has not been associated with FPV infection 
in cats nor has cerebellar hYpoplasla, an FPV induced lesion 
ln neonatal kittens, been seen ln pups. However, when neonatal 
kittens were infected with FPV (Csiza ,!! !!·• 1971), 
lntranuclear inclusions and extensive fluorescence were 
observed ln myocardial cells 5 to 1J days postlnfectlon. 
In another study conducted on 8• to 9-week-old cats (Carlson 
et !!•, 1977), virus could be rec.overed from the heart but no 
inclusion bod.lea were observed. The virus may have been 
present ln the heart in these individuals because of a 
viremia following replication of the virus in endothelial 
cells (Csiza !! !!·• 1971) rather than myocardial cells. 
These two studies suggest that in the cat at least, 
myocardial cells of the neonate are more susceptible to 
17 
parv0virus infection than myocardial cells of older animals. 
Myocardial syndrome 
The clinical picture seen with the myocardial syndrome 
is one of sudden death with signs of acute respiratory 
ddstress occurring as a result of cardiac failure. The pups 
are uslially reported to be in good health prior to the 
episode which usually occurs after feeding (Thompson tl !!·, 
1979; Jezyk et al., 1979). On gross examination, pulmonary 
' --
congestion and edema are common and the myocardium, 
especially the left ventricle, will appear pale (Kelly, 1978; 
Thompson et al., 1979). Lymph nodes may be enlarged and 
.- --
edematous (Hayes !! al., 1979a; Thompson ,tl !!·, 1979) • 
. Histological examination of the heart shows non-
suppurative myooarditis with interstitial fibrosis and 
infiltration of plasma cells, lymphocytes, and some 
macrophages (Kelly, 1978; Jezyk ,tl !!•• 1979). The left 
side is usually more invilllved. In older animals, focal 
myocardial necrosis and mineralization have been observed 
(Jezyk tl !!.•• 1979). Basophilic homogeneous intranuclear 
inclusion bodies in myocardial cells may be seen scattered 
throughout the myocardium (Kelly, 19781 Thompson et al., 
--~ 
1979). ' 
The cause of death in the myocardial form of CPV 
infection depends on whether the infection ls acute or 
chronic. In SOiie pups, death occurs in the acute phase 'by 
18 
·conduction failure as determined by electrocardiograms 
(Carpenter, !!; !!·• 1980). Despite the observations by 
carpenter!!.!!· (1980), electrocardiogram findings have not 
correlated well with the severity of the myocardial lesions 
seen poatmortum and pups have died of mJooarditis within 24 
hours of a normal electrocardiogram (Lenghaus !! al., 1980). 
If the dogs survive the acute infection, they may still die 
as the result of extensive myocardial fibrosis which, by 
contraction of the musc.ulature, causes valvular 
insUfficiencies and congestive heart failure (Robinson !! 
al., 1980a1 Lenghaus !! !!_., 1980), 
Enteric syndrome 
The clinical signs of enteric CPV infection have been 
well-summarized by Appel !! !!.!· (1978). They include 
vomiting, diarrhea, rapid dehJdration, and anorexia. The 
feces is light gray in the early stage of diarrhea but may 
become hemorrhagic. Copious amounts of mucus have also 
been reported with the diarrhea (Gagnon and Povey, 1979). 
Temperatures from 40 to 41°c have been reported (Appel et 
. -
al., 1978), but i't is not a consistent finding, especially 
in older dogs. A leukopenia has been observed accompanying 
the fever with total counts of 500/mm3 to 2000/mm3 being 
reported (Appel !! !!·, 1978), but an absolute lympho.penia 
of <2,000/mm3 is a more consistent finding (Fritz, 1979: 
Appel!..!:. al., 1979). All ages of animals are susceptible 
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although the mortality rate appears to be higher in the 
younger animals. Most deaths occur within 24 to 48 hours 
of the first sign of disease which is ustla11y·vomition 
(Appel~ al., 1978; Fritz, 1979). The average mortality 
rate in litters has been estimated at 20% (Johnson and 
Spradbrow, 1979). 
Gross pathological lesions are confined to the 
intestinal tract. The gut is often distended with gas and 
the contents in the lower and middle small intestine are 
I 
I 
watery and may vary from light colored with a large amount 
of mucus to dark and hemorrhagic (Walker·~!!!·• 1979; 
Thomson and Gagnon, 1978). Shallow erosions with scant 
fibrinous exudate have also been reported (Thomson and 
Gagnon, 1978). 
The lesions seen on histopathological examination 
resemble those seen with FPV infection in cats (Kahn, 1978). 
There is severe loss of intestinal epithelium in the crypts 
of the s~all intestine with shortening of the villi. There 
is also a depletion and necrosis of lymphoid tissue evident 
in Payer's patohes as well.as lymph nodes, spleen, and 
thymus (9ooper ~ !!!, •• 1979; Nelson et!!_., 1979). Bone 
marrow sections show a marked depletion of mature elements 
of both red and white cell series (Kelly, 1978). 
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Properties of the Virus 
The characteristics of the family Parvoviridae have 
recently been reported by the Study Group on P~.1'.VoY-1rJdae, 
coordinating Subcommittee, International Committee on 
Taxonomy of Viruses (Bachmann et!!_., 19?9). Members of the 
family con-ta1n linear, single-stranded DNA with a molecular 
weight of between 1.5 and 2.2 X 106 daltons. The virions 
are isometric, nonenveloped particles, 18-26 nm in diameter 
wit;h icosahedral symmetry. The virion probably contains 32 
capsomers, 3-4 nm in diameter, but a configuration with 12 
caps0mers has also been suggested (Croghan, 1968:-Kongsvik 
et al., 19?4). The infectious particles have a buoyant 
density in CsCl gradients of between 1.39 and 1.42 g/cm3. 
The viruses are etl'!er- and chloroform-resistant, and. heat-_ 
and acid-stable (56°c, pH 3 for 60 minutes). Most members 
possess a hemagglutinin on the virion for at least one 
species of red blood cells. The viruses multiply in the 
nucleus a_nd replication is dependent upon certain functions 
of the host cell or helper functions provided by other 
viruses, 
The family Parvoviridae contains three genera. They 
are Parvovirus which contains viruses that can replicate in 
susceptible cell cultures without a helper virus, produce 
intranuclear inclusion bodies, and contain only plus strands 
of DNA: Adeno-associated virus which contains viruses that 
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are dependent OJ:l helper viruses (adenoviruses and to Solle 
extent herpesv'iruses), produce no detect~ble cytopathology, 
and contain either plus or minus strands of DNA; and 
' . 
Densovirus which contains parvoviruses of arthropods that 
can replicate without helper viruses, cause hypertrophy of 
the nucleus with formation of intranuclear masses, but have 
either plus or minus strands of DNA in the mature virus 
particles. It had been previously deter•ined by Johnson 
ll al., (1974) that based on size, buoyant density, and DNA 
characteristics, FPV and MEV aet the then existent 
classification requirements for Pe.rvovirus Subgenus ! set 
by· the International Co1111ittee on Virus Nomenclature 
(Wildy, 1971) and are now considered members of the genus 
.ParvoV"irus and strains of the species Feline Parvovirus 
(Bachmann ll al., 1979). 
Canine parvovirus has not yet been formally included 
in the genus Parvovir&s by the International Committee on 
Taxonomy of Viruses but it has been shown to possess the 
c11aracteristics of that group. Basophilic intranuclear 
inclusion bodies are a common observation in myocardial 
•, ' . ., 
-
cells of dogs with myocarditis (Kelly and Atwell, 1979; 
Huxtable ll !l·, 1979; Thompson ll !.!·, 19'/9) and both 
eosinoph111c and basophilic intranuclear inclusion bodies 
have been observed, though not consistently, 1n crypt 
epithelial cells of dogs with enteritis (Kelly, 1978; 
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.Fritz, 1979; Jefferies and Blakemore, 1979). The 
basophilic inclusion bodies seen in myocardial cells and 
some enterocytes may be indicative of older lesions since in 
cell cultures, parvovirus inclusions are at first lightly 
eosinophilic and then become basophilic with age (Cheville, 
1975). The particles observed by electron microscopy in the 
inclusion bodies associated with CPV infection (Huxtable tl 
al,, 1979; Jefferies and Blakemore, 19791 Hayes et al., - - --
i979b) and the feces of dogs with enteritis (Eugster tl !!•• 
1978b; Appel.!!! al., 1978, Black.!!!!!·· 1979) were 18-22 nm 
in diameter and res.em bled a parvovirus in morphology. 
Burtonboy tl al. (1979) described the intact particles as 24 
nm in diameter with an icosahedral shape and a buoyant· 
density of 1.4J g/cm.3 in CsCl. Canine parvovirus isolates 
from cases of enteritis were grown in primary canine fetal 
lung cells and a feline kidney cell line (Johnson and 
Spradbrow, 1979). Subsequent testing indicated that CPV 
possessed a hemagglutinin for red blood cells, resisted 
heating at 6o0 c for one hour, resisted a pH of J and ether 
treatment, and behaved as a DNA virus in the presence of 2 
bromodeoxyuridine; all characteristics of a parvovirus. More 
recen.tly, McMaster .!!! al., (1981) have shown by restriction 
enzyme analysis that a high degree of homogenicity exist in 
the DNA from CPV and MEV. Sixty-eight of 79 mapped sites 
were common and most .of the li restriction sites which were 
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different were in regions coding for viral capsid proteins 
which may account for slight serological differeno'1JS and for 
the difference in host c.ell range observed for the two· 
V·iruses. 
Relationships with Other Viruses 
Serological cross-reactivity 
Canine parvovirus has been found to be indistin-
guishable from FPV and MEV by HI or SN tests (Carmichael il 
al., 1980; Black et al., 1979; Johnson and Spradbrow, 1979) - --
which is in.agreement with eariier studies that indicated 
no serological differences between FPV and MEV (Johns.on, 
1967)., Lenghaus and Studdert (1980) reported that CPV was 
significantly different from FPV by SN but not HI. There 
was, however, only a 4-fold increase in antibody titer when 
C.PV was neutralized by the homologous antiserum o'V'er the 
titer obtained with the same serum and FPV. This author 
feels that the difference was too small to be significant. 
An apparent cross-reaction between CPV and fluorescent 
antibody (FA) conjugate to porcine parvovirus has been 
reported (Black!! al., 1979; Eugster, 1980). The extent 
of this cross-reactivity and its occurrence with FPV and MEV 
has not been examined, There appears to be no relationship 
between CPV, FPV, or MEV and MVC (Carmichael!! al., 1980; 
Siegl, _ 1976), 
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Hemagglutination reactions 
The difference in hemagglutination (HA) reactions for 
I 
CPV, FPV, and MEV may serve as a means of differentiating 
the three viruses. Johnson and Cruikshank (1966) indicated 
MEV or ultrasonioated FPV would hemagglutinate pig 
erythrocytes at q.oc but not room temperature. Further 
studies by one of the authors (Johnson, 1971) indicated 
6 locally isolated MEV strains agglutinated pig cells while 
10 local isolates of FPV did not. Because the 16 viruses 
tested were really different isolations and not necessarily 
different strains, the uniformity of the agglutination of 
pig erythrocytes by MEV but not FPV was not truly 
established, 
Johnson and Spradbrow (1979) indicated that CPV from 
oases of enteritis would aggiutinate pig and monkey 
(cynamologous ·and crab~eating Macaque) erthrocytes at 4o 
and 25°c, with the reaction at 25oc differentiating it from 
FPV and MEV. The authors cite one author's previous study 
(Johnson and Cruikshank, 1966) to state that FPV (and 
presumably MEV) will not agglutinate monkey erythrocytes, 
but the.article cited does not specify the species of cells 
with which negative hemagglutination reactions occurred, In 
another article by this same author (Johnson, 1971), rhesus 
monkey, horse, and oat erythrocytes were among those tested 
that would not agglutinate. 
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The hemagglut1nat1on reaction of fecal origin CPV with 
p1g and.monkey (rhesus) erythrocytes at 4°c was confirmed by 
Burtonboy tl !!!.· (1979). They d1d not incubate the test at 
25oc but obtained negative results at :37°c. Gagnon and 
Povey (1979) and osterhaus .!! al. (1980b) reported 
hemagglut1nat1on at 4°c with cat as well as p1g and rhesus 
monkey erythrocytes and an enter1c isolate of CPV, and 
Robinson tl !!!.· (1979) 1nd1cated that myocardial isolates of 
CPV agglutinated p1g erythrocytes at room temperature. 
Kon1sh1 et al. (1975) demonstrated that the ability of 
, -- . 
FPV to .agglutinate pig erythrocytes was related to the pH 
at which the test was conducted. A viral preparation of 
FPV had an HA titer of 11.8 at pH 7.4; 1:64 at pH 7.0, and 
1:1,024 at pH 6.6 when incubated at 4oc. Seven isolates of 
FPV acquired at Tokyo University had similar HA patterns. 
No agglut1nat1on was seen with calf, horse, sheep, cat, 
guinea pig, chicken, or goose erythrocytes at pH 6.0-8~0. 
The failure of Johnson (1971) to note hemagglutinat1on with 
FPV may have been due to the pH ~sed 1n his testing but this 
ls conjecture since the actual pH used was not specified • 
. Carmichael .!! !!!.· (1980) studied the effect of pH on the 
agglutination of various species of erythrocytes at 4oc by 
CPV, FPV, and MEV. Canine parvovirus agglutinated p1g, 
rhesus monkey, horse, and cat erythrocytes over a wide pH 
range· (6.o, 6.8, and 7.2 ezoept for pig cells that 
'• ·. 
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spontanl(lously agglutinated at 6.0) with the highest titers 
occurr.1:ng ,with pig erythrocytes. Feline panleukopenia virus 
and MEV agglutinated rhesus monkey and horse cells at pH 6.o 
only and did not agglutinate cat cells. The results 
obtained with pig erythrocytes indicated a higher titer with 
·Fl?V thari with MEV. Although this is in contrast to earlier 
studies (Johnson and Cruikshank, 1966; Johnson, 1971), no 
apparent attempt was made in either study to standardize the 
CPV, FPV, and MEV preparations so that viral titers were 
similar. The agglutination of horse erythrocytes by CPV'is 
inconsistent with the negative results seen by Gagnon and 
Povey (1979) and Walker ll !!· (1979). A similar inconsis-
tency exists with FPV since Konishi ll al. (1975) reported 
no hem.agglutination with horse erythrocytes at pH 6.0. 
Moraillon et al. (1980) reported no differences in the . ··--
effect of pH on the hemagglutination reactions seen with CPV 
and MEV using cat and rhesus monkey erythrocytes but the 
strain o.f MEV used was from an outbreak of enter! tis in mink 
occurring in October, 1979, Since this ls after the 
appearance of CPV in Europe, and the pathogenicity of CPV· 
for mink has not been determined, the identification of the 
isolate as MEV ls questioned by this author. 
In summary, lt appears that at the proper pH, CPV, FPV, 
and MEV will all agglutinate monkey, pig, horse, and 
possibly cat erythrocytes. Differences in the agglutination 
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titers s·een with erythrooytes from various speoies may be an 
important tool· for differentiating the three viruse~ but 
these test should be standardized as were those by Toolan 
(1967) .and Hallaue'r ~ !l· (1972) where different agglut1-
nat1on patterns for rodent parvoviruses were determined 
after the viruses were diluted to oontain an equal HA titer 
with one speoies of erythrooytes. 
The use of the hemagglutinat1on test on feoal 
preparations .with either pig or rhesus monkey erythrooytes 
has been shown to be a sensitive diagno·stio aid· when used 
1n oomb1nation with an HI test to eliminate nonspeoifio 
hemagglutination (Carmichael et !l·, 1980). Pig erythro-
cytes. are preferred ()Ver monkey erythrooytes since the 
latter will also agglutinate 1n the presence of MCV .(Binn 
et al., 1970) .• -- . 
Speoies susoeptibil1ty 
In vitro Johnson an4. Cruikshank (1966) indicated 
that or·a wide range of· pr1nary and line oells, FPV and MEV 
would'only oause CPE in oat, tiger, mink,·or ferret tissue 
oultures; but they did not speoify the negative oells. In 
an· earlier publication (Jo!Ulaon, 1964), bovine, dog, monkey, 
h\iman epidermoid oancer cells, or HeLa cells were not 
affected by FPV. Lee ~ !l· (1969) observed 1ntranuclear 
inclusiol'I; bodies in feline and lion cells infected with FPV 
but not dolphin, racooon, mink, pig, rabbit, bovine, whale, 
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or bat cell lines or primary dog kidney cells. Scott !1 al. 
(19?0) confirmed these finding~. 
Intranuclear inclusions caused by CPV have been 
obs.erved in both feline and canine cells (Johnson and 
Spradbrow, 19?9; Mc.Candlish !1 !.!•, 19?9) with feline cells 
appearing to be more susceptible (Black et!!_., 1979; 
Mccandlish !1 al., 19?9). Intranuolear inclusions were 
either not seen or were considered indefinite when CPV was 
inoculated onto Vero cells (Johnson and Spradbrow, 19?9) or 
Madin-Darby bovine kidney cells, primary human embryo 
kidney cells, primary rhesus monkey kidney cells, and HeLa 
cells (Burtonboy !1 !.!·· 19?9). However, when a fluores-
cent antibody test was used as an indicator sy.ste11 (Appel et 
al,, 19?9), Vero cells", raccoon salivary gland cells, and 
bovine fetal spleen cells in addition to canine, feline, and 
mink cells were found to be susceptible. Intranuclear 
inclusions were prominent only in feline kidney cells. 
Canine parvovirus appears to have a wider host range in 
vitro than FPV or MEV. However, the studies conducted with 
FPV utilized the presence of CPE rather than specific 
fluorescence as an indicator system. Very little work has 
been done with MEV to establish its in vitro host range. 
Feline panleukopenia virus has been isolated 
from domestic oats, leopards, tigers, lions, and panthers, 
and most probably all members of the family Felidae are 
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naturally susceptible (Siegl, 1976). The pathogenie1ty of 
FPV for-mink (family Mustelldae) ls questionable. Gorham 
et al. (1966) and Farrell et al. (1972) eoUld not produce · -- - --
disease in 1111n11:·w1th an FPV isolate that was highly patho-
genic for oats. Burger (1961) e:z:perleneed similar problems 
iri produelng enter1 tis in mink but ooUld get dlseas_e 
symptoms if- he gave the alnk hydrooortlsone or exposed them 
to l300 r of whole body rad1at1_on. Continuous passage in 
mink or alternate passages in mink and eats ooUld not 
' 
increase.the virulence of FPV for mink. MacPherson (1956) 
on the other hand, did produce enteritis in aink by giving 
them portions of spleen, liver, and bowel froa the carcass 
of a cat which had died with typical symptoms and clinical 
signs of FPV. Whether the oat coUld have been infected-with 
MEV and not FPV was no.t -de clear. Feline panleukopenia 
virus has been shown not to be an enterio pathogen of 
ferrets, another member of the family Mustelldae (Burger, 
1961), but will cause cerebellar hypoplasia in neonatal 
ferrets (Johnson il !!!·• 1967; Duenwald,!!.!?, al., 1971). The 
isolation of a virus with characteristics of either FPV or 
MEV from coati-mundi which were in close contact with cats 
(Johnson and Halliwell, 1968) and an outbreak of enteritis 
in raccoons in 1939 caused by an agent that produced 
disease typical of FPV when inoculated into oats (Waller, 
1940) woUld tend to indicate that members of the family 
I 
I 
I 
J 
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Procyanidae are also susceptible to enteric infections with 
FPV. The susceptibility of the raccoon to FPV was experi-
mentally confirmed by Burger (1961). Although replication 
of FPV in dogs has been·reported (Appel et al., 1980a), no ---- - . 
clinical signs nave ever been observed (Appel~!!!.·· 1980a; 
Hindle and Findley, 1932; Urbain, 19JJ), 
Mink enteritis virus is, of course, pathogenic for one 
member ot' the family Mustelldae, mink. The pathogenicity 
for ferrets has not been definitely established and 
Schofield (1949) .and MacPherson (1956). indicated they were 
resistant to infection, Cats are susceptible to MEV but to 
a mmch lesser degree than mink. Wills (1952) reported that 
"under strictly controlled conditions, tissues from infected 
mink produced leucopenia in kittens." No experimental 
details were given. ·MacPherson (1956) produced a ma.rked 
diarrhea J and 4 days postchallenge and a temperature of 
4o 0 c 7 days postchallenge in 1 of 24 cats fed mink enteritis 
material. The leukocyte count remained normal which 
suggests . that the diarrhea may not have been ot' viral 
etiology. The susceptibility of the 24 cats for MEV was 
questioned by the author since he was also unable to produce 
clinical disease in 14 cats given material from a ":typical 
case of feline enteritis." Burger (1961) had results similar 
to those of Wills (1952) in that he could produce a leuko-
penia but no signs in susceptible cats given MEV. When MEV 
Jl 
was given to raccoons (Burger, 1961), 8 of 9 animals 
remained well while the other developed a diarrhea on day 9. 
Canine parvoTirus has been associated with cas'es of 
enteritis in the dog as well as other members of the family 
Canidae including the coyote, bush dog, maned wolf and crab-
eating fox (Evermann ,!!! !!_., 1980; Fletcher,!!!!!_., 1979; 
Mann !1 !!_., 1980). Canine parvovirue has also been 
.suggested as the cause of an outbreak of severe enteritis 
in raccoons (Nettles,!!!!!_., 1980) but the lack of high 
antibody titers in sera from the raccoons and negative 
serological results against FPV causes this author to doubt 
the diagnosis. Similar outpreaks of enteritis had been 
occurring in raccoons since October 1976 and this was long 
before there was any serological evidence of CPV in the 
United States. 
The pathogenicity of CPV for members of the families 
Mustilidae and Felidae have not been established as of this 
da.te. Moraillon ,!!! !!!_., (1980) reported that the virus from· 
a naturally occurring outbreak of enteritis in mink would 
produce disease identical to CPV when fed to young pups .• 
Although hemagglutination studies are not definitive, the 
virus appeared to be closely related to CPV. This and the 
fact that the isolation from mink was made after CPV was 
present in the country suggests that CPV caused the 
enteritis in mink instead of MEV being pathogenic for dogs. 
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Osterhaus et al., (1980b) reported a slight temperature rise 
and a gradual fall in total leuoooyte counts, but remaining 
within the normal range, in one FPV susceptible oat given 
CPV. Although no response to challenge was seen in another 
oat that was immune to FPV, the lack of a significant number 
of animals in the experiment limits the value of any con-
clusions that can be drawn from it. 
An outbreak of gastrointestinal disease in laboratory 
personnel occurring simultaneously with an outbreak of CPV 
at a laboratory colony has been reported (Fritz, 1979) 
indicating that the host range of CPV might include man, 
but a relationship with CPV could not be established. 
Further, sera from humans who had diarrhea after handling 
CPV infected dogs were negative for CPV antibody (Appel ~ 
!!, •• 1980b). 
Vaccination 
When mink enteritis spread through the fur industry 
during the early 1950s resulting in great economic losses, 
heterologous FPV vaccine manufactured for use in oats was 
employed as a means of protection and was shown to be 
efficacious in mink (Wills and Belcher, 1956). Since that 
time, the ability of FPV ~nd MEV to immunize against one 
another has been well-established (Gorham~ al., 1965; 
Gorham et!!,., 1966; King and Gutekunst, 1970). When CPV 
33 
emerged in 1978 as an important pathogen of dogs, the close 
serological relationship between FPV and CPV led to.the 
recommendation that commercially available FPV vaccines be 
used once again for the prevention of a heterologous disease, 
CPV enteritis (Appel, 1979; Johnson and Spradbrow, 1979; 
Royal College of Veterinary Surgeons, 1979). Because the 
pathogenicity of modified-live FPV in dogs had not been 
established, the use of only inact.ivated vaccines was 
recommended. 
Experimental confirmation of the efficacy of F~V 
vaccine in preventing CPV caused disease was first presented 
by Appel~!!!·· (1979). Although serological conversion 
.was obtained in all vaccinated dogs, and dogs vaccinated 
twice with inactivated or once with modified-live FPV 
' vaccine did not develop elevated body temperature or 
lymphopenia; pyrexia and lymphopenia were the only signs of 
infection produced in the controls by the challenge prepa-
ration used in the experiment. Theref.ore, the efficacy of 
the vaccines in preventing CPV enteritis had not been 
established. 
In a~other vaccination-challenge experiment (Chapek ~ 
al •.• 1980), inactivated FPV vaccine was shown to prevent 
viral shed but the method employed, viral isolation from 
rectal swabs, is considered by this author to be less 
sensitive than the method.employed by Carmichael~!!!· 
J4 
(1980) in which 10% fecal preparations were tested by 
hemagglutination. Isolations were made on day 4 to 7 by 
rectal swabs as compared to days J to 9 by hemagglutination. 
Chapek et al. (1980) also stated that inactivated FPV --
vaccine protected dogs from leukopenia which was present in 
the controls. The severity of leukopenia produced and the 
percentage of controls in.which it was observed were not 
given. 
As stated earlier, the safety of live FPV vaccines in 
dogs had to be established prior to their being recommended 
for use in dogs. Although an early report (Lloyd-Evans, 
1980) indicated vaccine virus could not be recovered from, 
or identified by immunofluorescence in internal organs of 
newborn pups given FPV vaccine, Appel ~ al. (1980a) 
reported that small amounts of FPV were isolated from 
certain tissues of dogs vaccinated 2 to J days earlier. The 
authors suggested that the virus recovered was the result of 
replication in the dog and not Just residual vaccine virus. 
The authors also suggested that the replication of FPY in 
dogs accounts for the high and more persistent antibody 
levels seen following vaccination with modified-live as 
compared to inactivated FPV vaccines (Appel£!,!!_., 1979; 
Moraillon, 1980: Appel et al., 1980a). 
. --
Feline panleukopenia virus apparently does not 
replicate in all vaccinated dogs. In field trials in over 
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i·oo dogs, only 58'% of the dogs developed hemagglut1nat1on 
1nh1bit1on antibody levels of >1:80 (Carmichael and Pollock, - ' 
1981), Although comparable antibody titers are seen 
following the administration of a single dose of inactivated 
FPV vaccine (Appel~!!_., 1979), it was the view of the 
authors that in the majority of the dogs in which titers of 
~1:80 were generated, they were generated because of viral 
replication, The .authors also presented data that 
indicated 8 of 8 dogs given an experimental vaccine 
containing 107-5 tissue culture infective dose50 (TCID5o> of 
virus developed antibody titers of at least 1:80, while 
only 5 of 8 dogs given io5·5 TCID5o of virus developed 
antibody: levels of this magnitude. The authors concluded 
that the higher percentage of responding animals seen with 
the higher titered vaccine was due to viral replication and 
by increasing the virus titer, the proportion of.dogs in 
which the virus replicated, also increased. In actuality,' 
if viral replication.was a prominent feature of vaccination 
with modified-live FPV vaccine, there should not be as 
gl'.eat a .difference in the immunity produced. by a vaccine with 
105· 5. TCin50 of virus and one with 107 • 5 TCID50 of virus as 
replication of the virus in the host would soon equate any 
initial.differences. An increase in total antigenic mass in 
the higher titered vaccine with little or no increase in the 
proportion of vaccinated dogs in which replication occurred 
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seem a more logical explanation of the observed response 
d.ifferences. 
Vaccines produced from homologous CPV have also been 
developed. Appel et al., (19?9) demonstrated high post• --
vaccinal serology in dogs given an inactivated CPV vaccine,. 
The dogs were protected from challenge but, as mentioned 
earlier, the challenge was not capable of producing more 
than a lymphopenia and pyrexia in control dogs. Studies 
conduced by other investigators (Smith.!!!!·• 1980; Eugster, 
1980) using more virulent challenges have established the 
efficacy of inactivated CPV vaccines. The immunit}' 
generated by the inactivated CPV vaccine appears, P,owever, 
to be short-lived (Appel.!! al., 1980a; Carmichael ·and 
Pollock,. 1981). 
An isolate of live CPV was reported to be attenuated 
for pups after 80 serial passages in dog kidney cells (Appel 
.!! al., 1980a; Carmichael .!! !!·, 1981) and capable of 
producing a high initial antibody response and "long-lived 
immunity" (Carmichael and Pollock, 1981). Although no 
evid~nce of virulence has been observed with this attenuated 
&)rain of CPV when given alone to dogs, its use in a vaccine 
would most probably be in combination with other modified-
live viruses. Potgieter .!! al. (1980) reported the 
occurrence of enteritis and neutropenia in ) of ) dogs given 
CPV one week after being vaccinated with canine distemper 
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and infectious canine hepatitis vaccine; one dog died. 
Dogs not previously vaccinated remained clinically normal 
following exposure to the CPV preparation used. It has 
also been reported (Jezyk, 1980) that dogs given distemper 
vaccine while ill with presumed CPV enteritis have subse-
quently died with confirmed distemper. In light of these 
findings, the safety of modified-live CPV vaccine used in 
combination with other modified-live virus vaccines, should 
be established. 
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PART I. IDENTIFICATION OF CANINE PARVOVIRUS 
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INTRODUCTION 
Serologically CPV, FPV, and MEV appear to be 1nd1s-
t1ngu1shable from one another making 1dent1f1cat1on of . 
individual isolates difficult. This study examined several 
parameters; antigenic relationship to porcine parvov1rus 
(PPV), differences in hemagglut1nat1on activity, and.!!! 
vitro species susceptibility; to establish a simple method 
of differentiating the J viruses. 
Specific fluorescence with PPV conjugate and CPV has 
been reported, but the presence of a similar cross-reaction 
with PPV conjuga.te· and FPV or MEV has not been established. 
Hemagglut1nat1on 1nh1b1t1on tests have, however, indicated 
there ls no serological relationship between the latter 2 
viruses and PPV. In th1.s study, the· extent of the cross-
react1v1 ty of PPV antiserum with CPV, FPV, and MEV was 
examined by FA and SN tests to determine if it was a 
distinct characteristic of CPV. Bovine parvov1rus (BPV) 
was include~ in the FA test to further determine the extent 
of the cross-fluorescence reported with PPV conjugate. 
Although d1fferenc~s in the abilities of CPV, FPV, and 
MEV to agglutinate erythrocytes of various species have been 
reported, these differences appear to be .influenced by the 
pH at which the tests were conducted. An attempt was.made 
to dete~m1ne if the pH associated differences in HA titers 
seen .w1th the most reactive cell, porcine erythrocytes 
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(Carmichael et !!l•• 1980), were reproducible among isolates 
of each virus. 
A number of reports suggest that, based on the presence 
of intranuclear inclusion bodies, there are differences in 
.!!! vitro species susceptibility of CPV, FPV, and MEV. The 
FA technique was, however, shown to be more sensitive than 
inclusion body observations in detecting CPV in cells from 
various species. In this study, the presence of specific 
fluorescence was employed to determine differences in .!.!! 
vitro species susceptibility for several isolates of all J 
viruses. 
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MATERIALS AND METHODS 
Tissue Culture Procedures 
The medium used for all tissue culture procedures was 
Eagle's minimum essential medium with Earle's salts, L-
glutamine and nonessential amino acids1• To this, 5%' 
fetal calf serum and gentamycin,2 at a final concentration 
of 50 mcg/ml, were added~ The same m~dium, without fetal 
calf serum, was used as virus and serum diluent in all 
procedures except hemagglutination. 
The fluorescent antibody technique was the indicator 
system used to determine tissue culture infectivity. Eight 
chamber slidesJ were seeded with o.4 ml/well of suspended 
cells, 200,000 cells/ml. Wells were inoculated with 0.1 ml 
of virus or serum-virus mixture within 2 hours of seeding 
and incubated at J?OC in an atmosphere of 5% C02 until 
fixed in acetone and stained with fluorescein tagged 
c,onjugate. Cells were examined for typical tluorescerice 
using an Orthoplan4 microscope equipped with a 200 watt 
' . 
mercury light source and an 1nc1dent-11ght illuminator. 
1F-15, Grand Island Biological Company, Grand Island, 
New York •.. 
2Garamycin, Sobering Corporation, Kenilworth, New 
Jersey. 
·, , .. 
Jr.ab-Tak Products, Naperville, Illinois. 
4E. Leitz Inc., Rockleigh, New Jersey, 
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Virus titrations were stained at 5 days postinooulation 
while SN tests were stained at J days. 
Cross-Reactlvlty with PPV 
Fluorescent cross•reaotivity 
Cells Crandell feline kidney (CRFK) cells were used 
to propagate CPV, FPV, and MEV; PPV was grown in embryonic 
porcine.kidney (EPK) cells. Cross-reactivity with BPV was 
included in the test design and the virus was propagated in 
primary bovine lung (pBL) cells. 
Viruses · The CPV used was the KB strain obtained 
from a dog in Ames, Iowa that was showing typical signs of 
canine parvoviral enteritis. The virus had been passaged 
twice in CRFK cells. The FPV was the ICK-JJ challenge strain 
that had been passaged 5 times in CRFK cells. The MEV, here 
designated MEV-2, was a tissue culture adapted strain 
obtained from a commercial producer of MEV vaccine. It was 
passaged once in CRFK cells after receipt. Even though this 
virus may not have been used in the production of a vaccine, 
the actual source of this virus or any other virus .obtained 
from a biologies manufacturer will not be given because of 
the possibility of disclosing proprietary information. The 
PPV used in this study was lot Tc-J of a virus that had been 
isolated from porcine trypsin (Croghan~ al., 1973) and 
passaged Jtimes in EPK cells. The HADEN strain of BPV 
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(Abinanti and Warfield, 1961) adapted to bovine lung cells 
.was used. 
Conjugates The FPV conjugate was prepared from 
rabbits hyperlmmunized with the ICK-33 virus strain, the 
PPV conjugate was prepared from a sow vaccinated and then 
challenged with PPV, and the BPV conjugate was prepared from 
a calf hyperi111111unized wi.th the HADEN virus strain. 
~ design Between 100 and 1000 TCID50 of each 
vlrus·were inoculated. onto the applicable cell culture. 
Three days postinoculation, the infected cell cul t.ures were 
fixed, stained with each conjugate, and examined for 
typical parvovlral fluorescence. Uninoculated control 
cultures were treated in a.similar manner • 
. serum ·neutrallzatlon cross-reac ti vi ty 
The cells and virus strains used in this study we:re 
identical to those used in the fluorescent cross-reactivity 
test except that BPV was excluded from the study. Any 
cross-reactivity between BPV and PPV would not be a factor 
in differentiating CPV from FPV and MEV, and viral neutral~ 
izatioi::I. of CPV, FPV, or MEV should not occur unless. cross-
fluciresce'nce was firs.t present, A constant serum-varying 
virus neutralization test was conduced with a porcine 
orlgin ~PV antiserum wlth an SN titer of 1:6912 and a 
porcine serum free of SN antibody to PPV. Each were 
diluted 1:5 and mixed with an equal volume of 10-fold 
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dilutions of virus; PPV, CPV, FPV, and MEV. After 
incubation at room temperature for JO minutes, the virus-
serum mixtures were inoculated, 4 wells/dilution, into S-
chamber slides containing freshly planted EPK cells (PPV) 
or CRFK cells (CPV, FPV, and MEV). Three days postinoc-
ulation, ·the slides were fixed and stained with PPV or FPV 
conjugate. Each well that contained at least one 
fluorescing cell was considered positive and virus titers 
were determined by the Spearman-Karber method as refined by 
Finney (1971). 
The antibody titer of the pp_v antiserum was determined 
against each virus. Two-fold dilutions of serum were mixed 
with each virus preparation diluted to contain 200 TCID50/ 
0.1 ml. The virus-serum mixttlres were then incubated and 
inoculated onto cell cultures in the same manner described 
for the constant serum-varying virus neutralization test. 
After staining, each well that was free of fluorescing cells 
was considered positive and the antibody titers were 
calculated by the Spearman-Karber method. 
Hemagglutination Reactions 
The effect of pH on the HA titers observed with several 
strains of CPV, FPV, and MEV was determined as was the 
relationship between HA titer and infectivity titer. 
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Viruses 
The CPV strains utilized were FLFl-2, a challenge strain 
that had been passaged twice in embryonic feline f ibrobast 
cells. after being isolated from a dog in Ames, Iowa that 
died of canine parvoviral enteritis; KB strain previously 
described; A?B-22 strainl passaged once in CRFK cells; and 
the TN-2JJ strain2 that had been passaged approximately 40 
times in CRFK cells prior to receipt. The MEV strains 
'utilized were MEV-2, previously described; MEV-1, a mink 
tissue origin challenge strain; and MEV-J, another tissue 
culture adapted strain. The FPV strains included in 
this study were the ICK-JJ strain, previously described; 2 
isolates of the Johnson strain, here designated FPV-J1 and 
FPV-J2; the Crawley strain, FPV-C1; and the Gorham strain, 
FPV-Gl. The isolates of MEV and FPV were passaged once in 
CRFK cells.after receipt. Virus infectivity titers for all 
strains were determined by the fluorescent antibody technique 
described previously. 
Porcine erythrocytes 
'Ten ml of porcine blood were collected in an equal 
volume of Alsever•s solution. The cells were placed.in a 
1obtained from M.J.G. Appel, Ithaca, New York. 
2obtained from J.W. Black, Nashville, Tennessee. 
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polypropylene centrifuge tube and the volUlle raised to 50 
ml by the addition of Dulbecco•s phosphate buffered saline 
(PBS) free of ca++·and Mg++, The cells were then centri-
fuged at 500 X g for 10 minutes, decanted from the super-· 
natant, and resuspended in Dulbecco•s PBS. This washing 
procedure was repeated twice but the cells were not resus-
pended after the last centrifugation step. The packed cells 
were stored at 4oc for not more than B Hours before being 
used. 
Diluent 
Dulbecco•s PBS with 0.5% bovine serum albumin added1r, 
was used as diluent for viruses and erythrocytes. The PBS 
was divided into J lots. one lot was maintained at the 
initial pH of ?.4, one lot was lowered to ?.O, and the 
other lowered to 6. 6 by the addition of 1N HCl .• 
Test design 
The 12 virus strains were titered for HA activity at J 
different pH levels. The tests were conducted in 96-well U 
bottom microtiter plates.1 A variable volume multichannel 
pipette2 was used to deliver 0.05 ml of diluent into each 
well. A 0.05 ml pipette3 was used to dispense that volume 
1n;imateoh Laboratories Inc., Alexandria, Virginia. 
2T1tertek, Flow Laboratories Inc., Rockville, Maryland. 
3Med1cal Laboratory Automation Inc., Mount Vernon, NY. 
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of each virus into the first well. The multichannel 
pipette was then used to make 2), 2-fold dilutions, after 
which 0.025 ml of a lt suspension of packed porcine eryth-
rocytes in the appropriate pH diluent was added to each well. 
The plates were incubated at 4oc overnight and the HA titer 
recorded as the highest dilution of virus that would agglu-
tinate cells. 
ID Vitro Species susceptibility -
Cells 
The host-cell ranges of CPV, FPV, and MEV were eval-
uated in CRFK, EPK, and pBL cells previously described. 
Primary canine kfdney (pCK) cells, a mink lung cell line 
(MV1-Lu), a ferret lung cell line (FeL-MA1J9) a dog fibro-
blastic cell line (A-?2), MDCK cell line, and an African 
green monkey cell line (Vero) were also included in the 
study. 
Viruses 
The 12 viruses listed for the. HA reaction study were 
included in ·this study, Two additional FPV isolates were 
included. They were another Crawley isolate, FPV-C2, and a 
ferret tiss.ue culture adapted lsola te, FPV-Fl. 
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~design 
Preliminary studies in which 0.1 ml of undiluted 
MEV-2, ICK-33. FPV-Jl, and FPV-Cl were inoculated onto pDK 
cells, indicated that 1-10 fluorescing cells/100,000 cells 
would be detected with all 4 viruses when high infectivity 
titers were used (103·5 TCij:>5o for MEV-2 to 105.1 TCID50 
for ICK-33). In an effort to standardize this study, each 
of the 14 virus preparations used were diluted to contain 
approximately 1000 TCID50/0.l ml. The dilutions were based 
on previous titrations conducted in CRFK cells. Eight 
chamber slides planted with each cell type were inoculated 
with 0.1 ml/well, 4 wells/virus when the cells were approx-
imately 70% confluent. Twenty-four hours postinoculation, 
the cells were washed twice with tissue culture medium, the 
chambers refilled with medium, and incubated for an addi-
tional 3 days. At that time, the slides were stained with 
FPV conjugate and the number of fluorescing cells were 
determ,.ned. 
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RESULTS.AND DISCUSSION 
Cross-Reactivity with PPV 
Fluorescent cross-reactivity 
The presence of typical parvoviral fluorescence in 
infected cells s:tained with PPV, FPV, and BPV conjugates is 
recorded in Table 1. The cross•fluorescence observed with 
PPV conjugate and CPV, FPV, and MEV was considerably less 
brilliant than that observed with the J viruses and FPV 
conjugate or with the homol·ogous PPV system (Figure 1). 
The cross-reactivity appeared to be one-way since no 
fluorescence was noted between PPV and the conjugate for 
FPV. None of the parvoviruses appeared to cross-react with 
BPV. There was no discernible difference in intensity of 
fluorescence observed between CPV, FPV, and MEV with either 
PPV or FPV conjugates, No specific fluorescence was 
obs.erved in the uninoculated control cells. 
Serum neutralization cross-reactivity 
Although the antibody titers obtained for PPV antiserum 
against FPV and MEV were <1:2 in the varying serum-constant 
virus neutralization test (Table 2), the numbers·of 
fluorescing cells detected at the 1:2 dilution were greatly 
reduced from the number observed in the 1:2 dilution of the 
normal serum and virus, The resUlts of the constant serum-
varying'"virus neutralization test also indicated low level 
Figure 1. Fluorescent cross.;.reactivity with PPV conjugate: 
(a) FPV stained with FPV conjugate diluted 1:20, 
x 1)0; (b) PPV stained with PPV conjugate diluted 
1:20, x 1)0; (c) FPV stained with PPV conjugate 
diluted 1:20, x 1)0; (d) FPV stained with PPV 
conjugate diluted 1:4, x 250 
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Table 1. Fluorescent cross-reactivity between parvoviruses 
Virus 
PPV 
CPV 
FPV 
MEV 
PPV 
conjugate 
+ 
+ 
+ 
+ 
FPV 
conjugate 
+ 
+ 
+ 
BPV 
conjugate 
BPV + 
Table 2. serum neutralization cross-reactivity between 
parvoviruses; PPV antiserum 
Virus Virus titer& Log10 Antibody 
NS AS neutralized titerb 
PPV 6.5 J.O J.5 6912 
CPV 5.3 J.9 1.4 4 
FPV 6.1 4.5 1.6 <2 
MEV 4.5 J.5 1.0 <2 
avirus titer expressed in log10 TCID50/ml obtained with 
normal serum (NS) and PPV antiserum (AS). 
baeoripocal of serum dilution of PPV antiserum that 
would neutralize approximately 100 TCID of virus. 
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reduct1on w1th PPV ant1serum. The t1ters obta1ned for CPV 
and FPV after correct1ng for the 1:2 serum-v1rus d1lut1on 
were s1gn1f1oantly below (p <.05 and p <.01 respect1vely) 
the expected results based on previous t1trat1ons. The 
reduct1on seen w1th MEV was not s1gn1f1cant but th1s may 
have been due to the small number of prev1ous t1trat1ons 
performed rather than a difference in the neutral1zat1on 
characteristics of MEV. The mean and standard deviation of 
the infectivity titer for CPV was 105.4 ± .2 (n = 5), for 
FPV it was 106.7 :t ,2 (n = 11), and for MEV it was 104 •8 .±,, 
• J (n = J). 
Although the reductions 1n infectivity titer of CPV 
and FPV seen w1th the PPV ant1serum. were statistically 
significant, they were less than 102.0, the minimum level of 
reduction commonly considered significant for specific 
antibody neutralization. The results obtained from both 
test systems ind1cate serum neutral1zat1on: cross-reactivity 
with PPV antiserum. does not occur at a great enough level to 
be used as a method of differentiating CPV, FPV, and MEV 
from one another. 
Hemagglutination Reactions 
The var1at1on 1n hemagglut1nat1on redct1ons appeared as 
great among 1ndiv1dual isolates of a virus as it d1d between 
viruses. This ls true 1n both the relat1onsh1p of 
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1nfectivity titer to HA titer and in the effect of pH on HA 
titer (Table J), 
The HA titer/infectivity titer ratio appeared to 
decrease as the number of tissue culture passages of an 
isolate increased. This was true regardless of whether the 
virus was CPV, FPV, or MEV. The lowest ratios for the MEV 
isolates were seen with the tissue culture adapted strains, 
MEV-2 and MEV-J. Likewise, the TN-2JJ isolate of CPV with 
approximately 40 tissue culture passages had a lower HA 
titer/infectivity titer ratio than the other CPV straiJts; 
FLFl-2, KB, and A7B-221 'which had been passaged less than J 
times, With the FPV isolates, the ICK-JJ strain with only 
5 tissue culture passages had the second highest ratio while 
the .2 Johnson vaccine strains, FPV-Jl and FPV-J2 had the 
lowest. 
The HA titers of the CPV isolates were affected less by 
o~anges in pH than the FPV and MEV isolates; but again, the 
responses were not consistent among isolates. The HA titer 
of the tissue culture adapted TN-2JJ isolate increased by 
4-tolcl as the pH increased while the titer of the other 
isolates either remained unchanged or decreased. 
While the HA titers of all the FPV and MEV isolates 
decreased as the pH increased, the reduction ranged fr~m a 
4•fold decrease to >)2-fold decrease, The 2 Johnson strains 
· of FPV and the MEV-3 isolate of MEV showed the largest drops. 
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Table 3. Effects of pH on hemagglutination titers of CPV, 
FPV, and l'iEV 
Virus Strain Infectivity H 
titer 6.6 7.0 7.4 
CPV FLFl-2 5.oa 1024b 1024 512 
CPV KB 5.5 16,384 16,384 16,384 
CPV A78-22 5.4 2048 1024 2048 
CPV TN-233 6.7 256 512 1024 
FPV FPV-Jl 5.7 32 <2 ..::.2 
FPV FPV-J2 6.5 512 16 16 
FPV ICK-33 6.1 2048 128 256 
FPV FPV-Cl 5.7 2048 512 256 
FPV FPV-Gl 4.5 512 256 128 
IviEV l'iEV-1 5.0 16,384 4096 4096 
MEV l'iEV-2 4.5 256 64 64 
:rv;Ev MEV-3 4.5 64 8 '2 
arnfectiv1ty titer expressed in log10 TCID50/ml. 
bHemagglutinat1on titer. 
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In this test system, changes of less than an 8-fold were not 
considered significant, thus 1 FPV isolate, FPV-Gl, and 2 
MEV isolates, MEV-1 and MEV-2, reacted similarly to the CPV 
isolates. Hemagglutination reactions were, therefore, not 
reliable in differentiating CPV, FPV, and MEV. 
In Vitro Species Susceptibility 
All of the viruses tested were able to replicate in 
CRFK cells as evidenced by >1000 infected cells/well and a 
reduction in cell numbers due to the cytopathogenicity of 
the viruses. No specific fluorescence was detected in EPK 
cells or pBL cells with any of the 14 viruses used in the 
study. 
Although the CPV isolates tested were able to induce 
the formation of specific fluorescence in all 3 canine cell 
types, the A-72 cells appeared to be the most susceptible to 
CPV (Table 4). While none of the FPV isolates showed 
evidence of viral replication in canine cells, the challenge 
a.train of MEV (MEV-1) was able to induce fluorescence, but 
only in A-72 cells. The lack of fluorescence wlth MEV-2 
and MEV-3 may have been due to either their adaptation to 
CRFK cells, or to the use of lower titered inoculums for 
these isolates. In spite of the low amount of fluorescence 
seen wi.th MEV-1 in A-72 cells, the data obtained indicate 
that the ability of·CPV to replicate in A-72 cells to 
approximately the same degree as it does in CRFK cells is a 
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Table 4. Specific parvoviral fluorescence in canine cells 
Virus 
CPV 
CPV 
CPV 
CPV 
FPV 
FPV 
FPV 
FPV 
FPV 
FPV 
FPV 
MEV 
MEV 
Strain 
FLF1-2 
KB 
A?8-22 
TN-233 
FPV-Jl 
FPV-J2 
FPV-Cl 
FPV-C2 
FPV-Fl 
FPV-Gl 
ICK-33 
MEV-1 
MEV-2 
MEV-3 
Titer 
2.5a 
3.5 
3.5 
2.8 
3.5 
3.0 
).) 
3.8 
3.5 
3.5 
2.8 
3.8 
2.5 
2.5 
MDCK 
<Sb 
27 ± 14 
5-10 
<S 
NSF° 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
Cells 
pDK 
<S 
5-10 
<S 
<S 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
a1nrectivity titer of inoculum expressed in log10 
TCID50/o.1 ml. Titer was determined in CRFK cells. 
A-72 
>1000 
>1000• 
:>1000 
>1000 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
NSF 
5-10 
NSF 
NSF 
bAverage number of fluorescing cells/well. When the 
mean was between 11 and 1000, the mean + 1 standard deviation 
is given. -
c· No specific fluorescence. 
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characteristic that can be used to distinguish CPV from 
FPV and MEV. 
Although it appears CPV replicates better than FPV or 
MEV in m1nk lung. ferret lung, and Vero cells (Tabie 5), 
there is too much var1at1on among the isolates to make any 
definite conclusions on the usefulness of these cells :for 
virus identification. one reason is that the amount of 
fluorescence observed with MEV-3 in mink lung cells was 
more indicative of an FPV isolate than MEV. However. when 
the history of MEV-3 was investigated, it was discovered 
that the virus was obtained from R. H. Johnson. The 
similarities of the HA i:eactions (low HA titer/iru:ectivity 
titer rabio) of MEV-3 and the Johnson isolates of FPV 
(Table 3) suggest that MEV-3 may have· been misidentified at 
some time and that it is really the Johnson .strai_n of_J~y._ 
If this is true. then the ability to replicate in •ink lung 
cells to a greater extent than ferret lung or A-72 cells 
would be a characteristic of MEV that would differentiate it 
from CPV.and PPV. 
The ferret tissue culture adapted FPV-Fl strain did not 
replicate as well as expected in ferret lung cells. It may 
be tha·t the virus has_ been replicated in cells other than. 
lung and it is the inability to replicate in lung cells, not 
ferret cells, that. is the cause of the low number of 
fluorescing cells observed. 
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Table 5. Specific parvoviral fluorescence in non-canine cells 
Virus 
CPV 
CPV 
CPV 
CPV 
FPV 
FPV 
FPV 
FPV 
FPV 
FPV 
FPV 
MEV 
MEV 
MEV 
Strain 
FLF1-2 
KB 
A78-22 
TN-2.3.3 
FPV-Jl 
FPV-J2 
FPV-Cl 
FPV-C2 
FPV-Fl 
FPV-Gl 
ICK-JJ 
MEV-1 
f.EV-2 
MEV-J 
Titer 
3.5 
J.5 
2.8 
3.5 
J.O 
J.J 
3.8 
3.5 
3.5 
2.8 
J.8 
2.5 
2.5 
Mirik 
lung 
176 ± 37b 
>1000 
>1000 
56 ± 1.3 
<5 
NS~ 
<5 
NSF 
NSF 
<5 
NSF 
28 + 6 
JO ± 6 
<5 
Cells 
Ferret 
1ung 
26 ± 8 
>1000 
>1000 
.32 + 9 
74 ± 1.3 
5-10 
11 ± J 
<S 
<5 
<5 
<S 
17 ± 8 
<5 
NSF 
arnrectivity titer of inoculum expressed in log10 
TCID50/0.1 ml. Titer was determined 1n CRFK cells. 
Vero 
5-10 
27 ± 7 
5-10 
<5 
<S 
<5 
NSF 
NSF 
5-10 
NSF 
<S 
5-10 
NSF 
·<5 
bAverage number of fluorescing cells/well. When the 
mean was between 11 and 1000, the mean± standard deviation 
is ·give~. 
cNo specific fluorescence. 
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GENERAL DISCUSSION 
Although the fluorescent crosa-reactiTity with PPV 
conjugate and CPV has been confirmed, this study has shown 
that an equal reaction occurs with PPV conjugate and FPV and 
MEV. Thus, 1t can not be used to differentiate. CPV, FPV 
and MEV. Likewise, the low level serum neutralization 
detected with high t1tered PPV antiserum is not unique to 
any of the 3 viruses, 
The ability of CPV to agglutinate pig erythrocytes 
seemed to be affected less by an increase in pH than the 
agglutination capacities of FPV or MEV. It ls this author's 
opinion, however, that the magnitude of the difference ls 
not suff1c1ent to allow HA reactions to be used to 
differentiate CPV from FPV or MEV. What is of interest, is 
the low HA results obtained with the Johnson strain of FPV 
(and MEV-3 if it is truly the Johnson strain of FPV) com-
pared to the HA titers of the other strains of FPV. This 
may explain the negative HA results obtained by'Johnson 
with h1a isolate and pig erythrocytes and· the low HA results 
obtained.by Caraichael et al., (1980) where the Johnson snow 
•' .... , . --
leopar~. a.train was used as the type strain for FPV. The data 
\ . '. 
presented in this study indicate that this strain is not· 
representative of PPV. 
Of the ·methods tested, .!!! vitro species susceptibility 
appears to be the most reliable for differentiating CPV, PPV, 
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and MEV. However, since fluorescing cells can be detected by 
using inoculums with high infectivity titers, the mere pre-
sence of specific fluorescence in cells from a species is 
not sUfficient for virus identification. Even at 1000 
TCID50. low numbers of fluorescing cells were detected wit!h 
isolates of each virus in most cell types tested. Where no 
specific fluorescence was seen, an increase in the infec-
tivity titer of the inoculwn might have resulted in ob-
served fluorescence. It is suggested that the relative 
abilities of a virus to replicate in certain cells be used 
to differentiate the 3 viruses. The results of simulta-
neous titrations in CRFK, mink lung, ferret lung, and A-?2 
cells, should identify the viruses. Canine parvovirus should 
titer well in CRFK and A-?2 cells; FPV should titer high ,. ' 
only in CRFK cells; and MEV should titer high in CRFK cells 
and the titration res.ults in mink lung cells should be 
greater than the results in ferret lung cells. It is this 
multiple titration system that is being used at the National 
Veterinary Services Laboratories, Ames, Iowa, for virus 
identification. 
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PART II. EVALUATION OF THE EFFICACY OF FELINE 
PANLEUKOPENIA VIRUS VACCINES FOR CANINE 
PARVOVIRAL ENTERITIS 
6 .3 
INTRODUCTION 
When CPV emerged 1n 1978 as a pathogen of dogs, 1t was 
a un1que s1tuat1on because a vacc1ne for the d1sease, 1n. the 
form of FPV vacc1ne, already ex1sted. Pr1or to be1ng 
11censed for use 1n dogs, however, the eff1cacy of the 
heterotyp1c vaccine had to be establ1shed. This was 
d1ff1cult because, except 1n young pups, CPV produces a 
mild disease experimentally. A s1m1lar s1 t.uat1on most 
probably occurs after natural exposure with most 1nfeot1ons 
being subcl1n1oal or result1ng 1n only a trans1ent loose 
stool or d1arrhea that 1s not recognized as s1gn1f1cant by 
the owner (Osterhaus et al, 1980a: Pollock and McGregor, 
1980). 
Feline panleukopen1a virus vacc1ne for use 1n oats 1s 
considered sat1sfaotory by the USDA 1f 1t w111 induce 
protection against a challenge that can produce a leuko-
pen1a of s.,4000 cells/mm.3 or <25% of the prechallenge normal 
(Standard requirements, 1981). Leukopen1a ls not a 
prominent occurrence 1n CPV 1nfeot1on, so other measurable 
signs of 1nfect1on and cr1ter1a of s1gn1f1cance had to be 
established. This study deals with the development of these 
cr1ter1a and their subsequent use for evaluat1ng the 
efficacy of FPV vaccines for CPV enter1t1s. 
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MATERIALS AND METHODS 
Dogs 
F1fty-f1ve beagle dogs, 2 to J months of age, were 
obtained from sources known to be free of canine parvov1ral 
1nfection.1 susceptibility to CPV was confirmed by the 
. varying serum-constant virus SN test previously describ,ed, 
and all dogs had antibody titers <1:2. 
Vaccines 
Vaccines studied were commercially prepared FPV vaccines 
that contained ei.ther modified-live virus (MLV) or killed 
virus (KV). The HA titers of the vaccines were determined 
at a pH. of 6.6 by the previously described procedure. The 
infectivity titers of MLVvaccinee were detel'l!ined in CRFK 
cells by fluorescent antibody staining 5 days postinfection. 
Each vaccine was administered intramuscularly to 4 or 5 dogs. 
Revaccination occurred at the shortest interval recommended 
by the manUfactur.er (2 or J weeks). Sera were collected at 
the time of each vaccination and antibody levels determined 
" ~ 0 ~' I~ 
ag,1nst the KB isolate of CPV by the SN test pr_mo.i,t!:JlY 
described. The vaccines were not diluted except where --
otherWise indicated. ; -.-_ ,, 
1Thirty-eix,doge were from Cornell Dog Farm, Cornell 
University, Ithaca, New York; 15 doge were from the 
Department of Laboratory Animal Science, Cornell University, 
I.thaca, New York; and 4 dogs were taken by Caesarian section 
from a dam obtained from Laboratory Research Enterprises, 
K"lamazoo; Michigan. ' . 
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Challenge Material 
Two separate CPV challenges were used in the study. 
The firstl was a tissue culture preparation containing 
105.0 TCin50/ml. The second was FLFl-2, previously 
described, which also contained 105·0 TCID50/ml. No 
extraneous viruses were detected in either challenge 
preparation after 2 passages in pDK cells, A-72 cells (a 
canine fibroblastic cell line used for the detection of CCV), 
and Vero cells. The abilities of the challenges to produce 
significant effects of CPV infection were similar. 
one ml amounts of undiluted challenge were given 
orally to each dog 14 days after the last vaccination. 
Food was withheld from the dogs for 24 hours prior to 
challenge and the dogs were fed .immediately after challenge. 
Each dog was housed in a separate cage to facilitate the 
evaluation and collection of feces. 
Evaluation of CPV Infection 
Rectal temperatures and total and differential 
leukocyte counts were obtained from J days prior to 
challenge to 14 days postchallenge. Fecal samples ware 
collected on the day of challenge and each day thereafter 
for CPV hemagglutination testing; the physical appearance of 
the feces was recorded daily. Sera were collected on the 
1obtained from Norden Laboratories, Lincoln, Nebraska. 
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day of challenge and antibody levels determined as 
previously described. 
Leukocyte Counts 
Total leukocyte counts were determined using a semi-
auto~ ted electronic cell counter.1 Duplicate counts were 
obtained for each sample. If the counts did not exceed the 
J% error of the instrwaent, the 2 counts were averaged and 
corrected for coincidence. If the difference between the 
2 counts was greater than J%, the reading were disregarded 
and a new set of 2 counts was obtained. 
Differential leukocyte counts were conducted on 
stained smears.2 The absolute lymphocyte counts were 
calcUlated by mUl.tiplying the nwaber of lymphocytes counted 
in 100 cells by the corrected total leukocyte count and 
dividing by 100. 
Ha testing .Q!. feces 
Viral shedding was evaluated quantitatively by 
determining the amount of viral hemagglutinin present in the 
fe·ces' using a modification of the technique described by 
Carmicti&el et al, (1980). Two- to J-gram samples of fecal 
1coulter Counter Model ZBl, CoUlter Electronics Inc., 
Hialeah, . Florida. 
2wright 1 s Stain, Fisher Scientific Company, Fair Lawn, 
New Jerse~. 
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material were mixed with 5 ml of Dulbecco•s phosphate 
buffered saline. The suspended samples were centrifuged at 
i500 X g for 25 minutes, then 2 ml of the supernate from 
each sample was vigorously mixed with 0.2 ml chloroform. 
This chloroform treated sample was centrifuged at 1500 X g 
for 15 minutes. The supernate was removed and frozen at 
-10°c until tested for HA activity. 
The HA test was conducted in 96-well U-bottom 
microtiter plates. Dulbecoo•s phosphate bUffered saline, pH 
7.0, with 0.5% bovine serum albumin was used as a diluent, 
and prewashed pig erythrocytes, 1.0% in the above diluent, 
were the agglutinated cells. Each fecal sample was 
titrated in duplicate with 1 titration series being 
incubated for JO minutes at room temperature with CPV 
antiserum capable of neutralizing 2048 HA units and the 
other incubated with normal serum prior to making 2-fold 
dilutions, After the erythrocytes were added, plates were 
incubated at 4°c overnight. The highest dilution at which 
HA was detected was considered the endpoint titer. At least 
a 16-fold reduction in titer must have occurred after 
incubation with CPV antiserum before the HA was considered 
specific. 
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RESULTS AND DISCUSSION 
Seronegative Control Dogs 
Fifteen seronegative control dogs, in J groups of 5 
dogs each, were given the challenge preparation. The 
highest daily rectal tempera.ture obtained and the largest 
daily percent lymphocyte drop are presented in Table 6. In 
11 of the 15 dogs, these 2 events occurred on the same day 
indicating they were not random fluctuations. Based on 
these results, a febrile response of ~39,7°c and a 
lymphopenia of 250% of the prechallenge normal were 
considered criteria of significant CPV infection that could 
be reproduced by the challenge preparation at least 80% of 
the time, 
The clinical signs of enteritis observed after 
administration of the challenge preparation varied 
considerably from dog to dog (Table ?). Some dogs had no 
signs or only a transient loose pancake-like stool while 
others developed a pronounced diarrhea accompanied by copious 
amounts of light brown mucus and frank blood, No enter1c 
signs were noted prior to day 5 postchallenge except with 
dog 9261 which had a loose stool on days 1, J, and 4 
p~stcballenge. Vomiting was not a consistent observation, 
and was _occasionally noted prlor to challenge. Similarly, 
loose pancake-like stools were observed at times other than 
the postchallenge observation period, For this reason, 
Table 6. 
Dog number 
CI41 
CI45 
CI46 
CI49 
CI50 
9256 
9261 
9285 
9251 
9270 
CJ94 
CJ85 
CKOl 
CJ90 
CJ83 
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Highest febrile response and lymphopenia in 
seronegative oontrol dogs inoculated with CPV 
Peroent 
Temperatures oc lymphopenia 
J9.8 (5)a 02b(5) 
J9.8 (5,6) 79 (5) 
J9.7 (5) 78 (5) 
40.6 (6) 79 (5) 
41.0 (5) 59 (5) 
J9.8 (5) 67 (5) 
J9. J (6) 71 (5) 
39.9 (6) 48 (5) 
39,9 (5) 72 (5) 
39.7 (6) 71 (6) 
40.0 (5) 63 (5) 
39.6 ( 3) 64 (7) 
39,7 (7) 43 (7) 
39,9 (5) 58 (5) 
40.0 (6) 50 (6) 
anay postchallenge that highest temperature or peroent 
lymphopenia was observed is given in parenthesis. 
. bPercent reduction in absolute lymphooyte count from 
prechallenge normal level, 
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Table 7. Clihioal signs of enteritisa in seronegative 
oontrol dogs inoculated with CPV 
Dog number Dal 2ostchallen15e 
5 6 7 B 9 10 11 12 1) 14 
CI41 
CI45 D MBD BD L L 
CI46 L L D 
CI49 L L 
CI50 L L L 
9256 v MBD BL L L L L 
9261 L L L L L L D L L 
9285 L DV BD D LMB 
9251 DB LMB LMB L 
9270 M L L v 
CJ94 L VLM D L L v 
CJB5 L L 
CK01 LMB LMD L LMB L 
CJ90 MB MD v M 
CJSJ v 
aclinioal signs of en_teri tis were reported a~ follQ.W.~I D = diarrhea; M = mucus in feces; B = blood in feces; L = 
loose pancake-like stool; V • vomltus. 
71 
neither vomiting nor the preeenoe of a loose stool were 
considered as definitive signs of CPV infection. Those 
signs that were attributed to the challenge inoculum were 
diarrhea, defined as feoes that flowed down the inclined 
pan on the bottom of the cage, or the presence of mucus or 
frank blood in the feces. 
None of the fecal samples collected prior to day 4 or 
after day 8 postchallenge had HA titers above 1:16. The low 
HA titers that were seen were not reduced by incubation with 
CPV antiserum. Therefore, any HA activity seen prior to day 
4 or after day 8 was considered nonspecific. Those titers 
for the J groups of controls that were considered the reeu1t· 
of CPV infection are presented in Table 8. Hemagglutination 
titers of >1:64 were obtained in 14 of 15 doge. Dog CJ94 
developed an HA titer of 1164, 8 days postchallenge, but the 
titer was only reduced to 1116 by incubation with 
antiserum. Although the 1164 titer was probably due to the 
presence of CPV, the agglutination did not meet the oriterion 
of .a 16-fold reduction in the presence of antiserum and was 
thus considered to be nonspecific. 
Based on the results obtained with the challenge 
preparation of CPV in seronegative controls, 4 criteria of 
significant infection were established. They are: (1) 
rectal temperature ~39.7°c, (2) lymphopenia of ~50% of the 
prechallenge normal, (J) presence of enteric signs of 
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Table 8. Canine parv0virus hemagglutinin activity in feces 
of seronegative control dogs inoculated with CPV 
Dog n'llmber Dal EOstchallenge 
4 5 6 ? 8 
Ci41 a 2048b ~4096 2048 • • • .. '• 
CI45 2048 ?:,4096 ::4096 >4096 >4096 
CI46 ••• >4096 ::,4096 • •• • •• 
CI49 128 ::,4096 ::4096 1024 ••• 
CI50 • • • ••• ::,4096 :!_4096 • •• 
9256 64 >4096 >4096 1024 ••• 
9261 ••• 64 512 64 • •• 
9285 ••• 1024 256 512 • •• 
9251 128 512 ::,4096 >4096 ••• 
92?0 • • • • •• • • • 256 >4096 
CJ94 •.•. • • • ••• • •• . ... 
CJ85 • • • • •• ::,4096 512 • •• 
CKOl • • • • • • 128 . 64 256 
CJ90 ••• 512 .:;_4096 • • • .. -· 
CK83 • • • • • • 128 256 • • • 
· 8 No.specific hemagglutination detected. 
·biieciprocal of the highest dilution at which 
hemagglutinat1on was detected. 
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illness which were limited to diarrhea or blood or mucus 
in feces, and (4) presence of CPV hemagglutinin in the 
feces at a level of >1:64. The occurrence of these 4 
criteria in the 15 seronegative control dogs is summarized 
ln Table 9, The challenge preparation was considered 
capable of producing at least 3 of the 4 criteria in at 
least 80% of the controls, and this then was established as 
the minimum acceptable challenge level for a valid vaccine 
1mmunogenicity test. 
Modified-Live FPV Vaccines 
The initial vaccine trial in dogs was conducted with a 
serial of modified-live FPV vaccine diluted to a level that 
would be minimally acceptable for oats. The diluted vaccine 
had a viral titer of 103.1 TCID50/dose. Fourteen days after 
a· single vaccination only 2 of 5 vaccinated dogs developed 
measurable antibody levels (1:3 and 1:4). The immunity of 
the vaccinates was challenged at that time and all dogs 
developed at least 2 of the 4 criteria of CPV infection. 
These results indicate that a vaccine that met the minimum 
acceptable titer for immunizing oats did not contain 
sufficient antigenic mass initially, nor was it able to 
induce sUffioient viral replication after inoculation, to 
immunize dogs. 
Undiluted vaccines were also evaluated in dogs (Table 
10), The vaccines were produced by 3 different manUfacturers, 
?4 
Table 9. Presence of challenge criteria in seronegative 
control dogs inoculated with CPV 
Group Dog number Criteria Present3 
I CI41 T L H 
CI45' T L c H 
CI46 T L c H 
CI49 T L H 
CI50 T L H 
II 9256 T L c H 
9261 L c H 
9265 T c H 
9251 T L c H 
9270 T L c H 
III CJ94 T L c 
CJB5 L H 
CK01 T c H 
CJ90 T L c H 
CJB'.3 T L H 
8 Criteria present reported as follows: T = temperature 
.?39.?0 c; L = lymphopenia ot a:!)O% of prechallenge normal; C = 
clinical Si Eros of ent.eri.tls whiQ.h '!l'ere, limi t.e"' __ to_ _!!_~!lrrhea _o_:r_ 
blood or mucus in feces;· H = hemagglutination titer,>1164 in 
feces. · -
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Table 10. Serological and CPV challenge results in dogs 
vaccinated with modified-live FPV vaccine 
Vaccine Titer Dog Seroloe;~ Results of 
number One dose Two doses challengeb 
Firm A 105.2c 9281 ~ 7 T L c H 
Serial 2 120d 9252 ~32 ,?243 Protected 
9253 3 2 L c H 
9288 8 ~243 Protected 
9283 2 2 T L c H 
Firm B 105·3 CP12 <3 3 Protected 
Serial 1 128 CP13 <3 21 Protected 
C096 5 47 Protected 
C097 7 36 Protected 
aaeciprocal serum dilution that neutralized 100-300 
TCID50 of canine parvovirus. 
baesults of challenge reported as follows: T = 
temperature >39.70C; L = lymphopenia of >50% of prechallenge 
normal; C = c;J..inical sign_s Of enteritis which we_r_e :U,J!lj,_1;~_4 _to 
diarrhea or blood or mucus in feces, H = hemagglutination 
titer ~1:64 in feces. 
crnfectivity titer expressed ln TCID50/dose. 
dHemagglutination titer. 
Table 10 (Continued) 
Vaccine Titer Dog 
number 
Firm B 105-0 CM67 
Serial 2 512 CM82 
CM70 
CM76 
Firm C 105°5 CM80 
2048 CM71 
CM69 
CM75 
eNot challenged. 
fNot applicable. 
' ' 
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Serolos~ Results of 
One dose Two doses challengeb 
7 47 Nee 
9 ~140 NC 
J6 ~140 NC 
~140 625 NC 
81 NAf NC 
47 NA NC 
47 NA NC 
~107. NA NC 
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and although the viral titers were oomparable (105.0 to 
105·5 TCID50/dose) there were greater differences in the HA 
' 
titers of the vaccines (128 to 2048). The serological 
responses and subsequent protection from immunity challenge 
elioited by the vaccines appeared to correlate better with 
the HA titers than with the infectivity titers. For 
example, with the 2 serials from firm B, the better 
· serologioal responses were seen with serial 2, the serial 
with the higher HA titer but the lower infectiv1ty titer. 
As data were evaluated from vaccination-ohallenge 
trials, it became apparent that as the antibody titer 
inoreased, the likelihood of protection from the effects of 
the challenge preparation also increased (Table 11). Sinc.e 
1:11 was the highest antibody level shown to be non-
protective, it was deoided not to challenge the dogs 
vaccinated with serial 2 from firm B, or the serial from 
firm c. The lowest individual antibody titer induced by 
each vaccine was 1:47. 
The possibility of a rectal temperature of ~39.7oc · 
occurring by chance instead of as a result of the challenge 
exists and was seen in J.of 20 vaccinates that were other-
wise considered protected. The 20 dogs did not develo~~----~ __ 
lymphopenia of z50% of the prechallenge normal, fecal hem-
agglutinin z1:64, or clinical signs or enteritis following 
challenge. The J dogs with elevated temperatures were 
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Table 11. Comparison of prechallenge serological titer• 
and the effects of CPV challenge 
Prechallenge serology8 Results of challengeb 
<2 T 
<2 T L c 
<2 T L c 
<2 L c 
<2 Protected 
<2 c 
2 T c 
2 T L c 
J Protected 
J c 
3 Protected 
4 c 
4 T c 
7 T c 
8 Protected 
aReciprocal serum dilution that neutralized 100-JOO 
TCID50 of canine parvovirus. 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
H 
~esults of challenge reported as follows: T = 
temperature ~J9.7°c; L = lymphopenia of z50% of prechallenge 
normal; C = clinical signs of enteritis which were limi.ted. to 
diarrhea or blood or mucus in feces. H = hemagglutination 
titer ~1:64 in feces, 
Table 11 (Continued) 
Pre challenge serology 
10 
11 
12 
12 
14 
16 
21 
23 
23 
36 
47 
62 
107 
107 
243 
::>243 
>243 
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Results of challenge 
Protected 
L C 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
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excitable animals that showed similar temperatures during the 
J days prior to challenge, Although none of the 20 
vaccinates considered protected had lymphopenias of ~50% of 
the prechallenge normal (mean maximum lymphopenia 31 ± 12%) 
4 dogs had lymphopenias of :> 45%. To what extent viral 
replication in these clinically protected dogs may have 
influenced temperatures and lymphocyte counts is not known, 
but since elevated temperatures can occur in excited dogs, 
and fluctuations in lymphocyte counts of ~50% seem possible, 
it was decided to consider a dog protected unless at least 
2 criteria of significant parvovirus infection were present. 
Inactivated FPV Vaccines 
Preinaotivation titers of the killed FPV vaccines 
evaluated in dogs were not available, The HA titers of the 
vaccines correlated positively with the serological 
responses and immunity to CPV infection produced by the 
vaccines; The results (Table 12) are ranked by ascending HA 
titer. Although the vaccine from firm X did not protect 
dogs with 2 doses, .the manufacturer had previously 
d.emonstrated that .1 dose of vaccine would immunize oats 
against feline panleukopenia, It therefore appears that the 
minimum antigenic mass necessary to immunize dogs is greater 
than the amount necessary to immunize cats. ·- . - ~ . 
The dogs vaccinated with serial 2 from firm Z were not 
immunity challenged because the high neutralizing antibody 
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levels produced indicated protection (see above). These 
dogs were maintained in isolation to determine the duration 
of immunity produced by the vaccine. The antibody titers 
obtained at monthly intervals dropped sharply, and by 2 
months after the second dose, the geometric ,mean antibody 
titer was only 1:169. After the initial drop, the antibody 
titers remained fairly constant (fluctuating within a J-fold 
range). The geometric mean antibody titer 8 months after 
the second dose was 1:207. Control dogs from the same 
litter housed with the vaccinated dogs remained seronegative, 
and in vitro testing of the vaccine used to immunize the 
dogs, failed to detect any viable virus. 
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Table 12. Serological and CPV challenge results in dogs 
vaccinated with inactivated FPV vaccine 
Vaccine 
Firm X 
Firm Y 
Serial 1 
Firm Z 
Serial 1 
HA 
titer 
2 
128 
512 
Dog 
number 
CJ87 
CK02 
CJ84 
CJ9J 
CJ98 
CJ92 
CJ91 
CJ95 
CJ96 · 
CJ82 
CP15 
CP16 
C098 
C099 
Serolo518 Results ofb 
One dose Two doses challenge 
<J 
<J 
<J 
7 
J 
<J 
<J 
4 
<J 
<J 
4 
<J 
4 
<J 
4 
2 
<2 
7 
2 
10 
8 
2J 
14 
J 
12 
16 
12 
62 
L 
L 
H 
H 
Protected 
TL 
L 
H 
H 
Protected 
Protected 
Protected 
Protected 
Protected 
Protected 
PI"otec ted 
Protected 
Protected 
8Reciprocal serum dilution that neutralized 100-JOO 
TCID50 of canine parvovirus. 
'biiesults of challe~ge reported as follows: T = 
temperature >J9.7oc; L = lymphopenia of >50% of prechallenge 
normal; c ... clinical s1gnsof enteritis which were limited to 
diarrhea or blood or mucus in feces, H = hemagglutination 
titer ~1:64 in feces, 
8J 
Table 12 (Continued) 
Vaccine HA Dog Serolo11::v8 Results ofb 
titer number One dose Two doses challenge 
Firm Y 1024 9282 5 2.3 Protected 
Serial 2 9280 4 11 L c 
9260 .32 24.3 Protected 
9286 14 107 Protected 
9250 >.32 107 Protected 
Firm Z 2048 14 280 .?;925 NC 
Serial 2 10 187 ~1.398 NC 
7 187 ~1.398 NC 
1.3 124 ~9.35 NC 
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GENERAL DISCUSSION 
The establishment of the 4 criteria of significance for 
signs of experimental CPV infection made it possible to 
objectively evaluate the efficacy of FPV vaccines for CPV. 
It was. demonstrated that when sUfficient antigenic mass, as 
measured by the HA test, was present in either a MLV or KV 
vaccine, the vaccine induced protection against clinical 
CPV. 
Whether a vaccine was capable of preventing infection 
by CPV was not established in this study. Other workers. 
have indicated that HI titers of 1:256 (Smith~!!_., 1980) 
and 1:80 (Carmichael and Pollock, 1981) were necessary to 
prevent viral infection. Since the SN test has been shown 
to be more sensitive than the HI test (Pollock and 
Carmichael, 1982), it is doubtful that an SN titer of 1:12, 
which appeared in this study to be protective against the 
clinical manifestations of CPV, would actually prevent 
infection. 
Presently, a serial of KV vaccine is considered 
satisfactory if 4 of 4 vaccinated dogs are protected from 
immunity challenge. Protection is defined as the presence 
of not more than 1 of the criteria of infection following 
exposure to a challenge that produces at least J of the 4 
criteria in 80% of the susceptible control dogs. Early in 
the evaluation of vaccines for CPV, it became apparent that 
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there was a strong positive relationship between increasing 
antibody titers and protection from challenge. In oats, a 
neutralizing antibody titer of 1:4 is considered protective 
by the USDA (Standard requirements, 1981) and a serial of 
inactivated FPV vaccine that can generate neutralizing 
antibody titers of at least 1:8 in J of 4 vaccinates and 
not .less than 1:4 in the remaining vaccinate is. considered 
satisfactory for release without immunity challenge of the 
vaccinates. From the data generated by this study, it 
appears that a similar serological test can be instituted 
for KV vaccines for CPV. If a serial of vaccine can 
produce neutralizing antibody titers of at least 1:16 in 
J of 4 vaccinated dogs while the remaining vaccinate 
develops an antibody titer of at least 1:8, the serial 
could be considered satisfactory for release without 
immunity challenge of the vaccinates. A seronegative dog 
housed with the vaccinates would be required to remain free 
of antibody as a control against postvaooinal exposure to CPV. 
An even better test for KV vaccines would be to 
release serials on their HA titer. The minimum post-
inao.t1vation HA titer necessary to immunize dogs could be 
determined in a large number of dogs to assure accuracy (20 
vaccinates and 5 controls). Once the minimum HA titer is 
established, each subsequent serial of vaccine must have an 
HA titer equal to or in excess of the minimum level in order 
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to be considered satisfactory. Depending upon the 
reproducibility of the HA test, a reference preparation 
with an HA titer equal to the HA titer of the vaccine 
tested in dogs may have to be run simultaneously with the 
serial of vaccine under test. 
It has been reported that FPV vaccine replicates in 
the dog, often producing high persistent antibody titers 
(Appel et!!_., 1980a). This might explain the extreme 
variability of the immune response seen with serial 2 from 
firm A. In the 2 dogs with high antibody titers, the virus 
apparently replicated. In the other 3 dogs, there appeared 
to be no viral replication and the antigenic mass present in 
the vaccine was not sUfflclent to produce immunity. 
Although the duration of the antibody responses was 
not compared, the titers generated by the modified-live FPV 
.. 
vaccines used in this study were similar to those seen with 
the inactivated FPV vaccines. This ls partlculary true when 
vaccines with the same HA titers are compared. For this 
reason, .it ls felt that in a large proportion of dogs, 
modified-live FPV vaccines do not replicate, but act 
instead like KV vaccines. 
It has been suggested by Carmichael and Pollock. (1981) 
that the percentage of .dogs in which PPV replication occurs 
can.be increased by increasing the 1nfect1v1ty titer of the 
vaccine. In that study, 8 of 8 dogs given 107·5 TCID50 of 
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FPV, 5 of 8 dogs given 105·5 TCID50 of FPV, and J of 8 dogs 
given 103·5 TCID5o of FPV developed RI antibody titers of 
~1:80, the level the authors considered protective. However, 
since .antibody t1.ters of this level are possible after a 
single dose of inactivated FPV vaccine (Appel~ al.,, 1979), 
the higher antibody titers seen with the higher titered 
vaccines may have been due to an increase in antigenic mass 
and not an increase in the-number of dogs in which viral 
replication occurred. Carmichael and Pollock also stated 
that when viral replication does occur, the resulting 
antibody titers will persist longer. However, in the study 
cited, the persistence of the antibody response was not 
determined, and therefore, an increase in viral replication 
with an increase in infectivity titer was not proven. 
Presently, a serial of modified-live FPV vaccine is 
considered satisfactory for marketing if its viral titer is 
at least 0.7 log10 above that required to induce protection 
from CPV challenge in at least 19 of 20 dogs with protection 
being defined as it was for KV vaccines. If viral 
replication can not be guaranteed, it seems more practical 
to consider a serial of vaccine satisfactory for marketing 
based on its total antigenic mass and not just its 
infectivity titer. With parvoviruses, the ability to 
agglutinate erythrocytes is a characteristic of mature 
infective virions, incomplete particles, and empty capsids, 
BB 
~11 of which are antigenic (Siegl, 1976). The HA test 
would thus appear to be a reliable test for antigenic mass. 
Additional testing will determine its usefulness as an in 
vitro tests for release for marketing of serial lots of MLV 
as well as KV vaccines. 
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SUMMARY 
In this study, methods of differentiating CPV, FPV, 
and MEV were examined and of the methods tested, !!! vitro 
species susceptibility was shown to be the most reliable. 
A procedure was proposed 1n which an unidentified virus 
would be titrated simultaneously in Crandell feline kidney, 
mink lung, ferret lung, and canine origin A-72 cells. Canine 
parvovirus should titer well in CRFK and A-72 cells; FPV 
should titer high only in CRFK cells: and MEV should titer 
high in CRFK cells and the titration results in mink lung 
cells should be greater than the results in ferret lung cells. 
It is this multiple titration system that is being used at 
the National Veterinary Services Laboratories, Ames, Iowa, 
for virus identification. 
The close serological relationship between CPV and FPV 
suggested that existing FPV vaccines could be used to 
immunize dogs against the effects of CPV. A vaccination-
challenge procedure was established to evaluate the efficacy 
of FPV vaccines. The results indicated that FPV vaccines 
could, indeed, be used to protect dogs against CPV enteritis, 
but the minimum effective dose for dogs was higher than the 
minumum effective dose for cats. It was also shown that the 
infectivity titer of a serial of MLV vaccine was less 
important than its total antigenic mass, as measured by the 
HA test, in predicting its efficacy. Minimum standard · 
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requirements that utilized the HA test were proposed for 
FPV vaccines intended for use in dogs. 
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